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ABSTRACT

NIH guidelines recommend treatment of moderate or severe childhood asthma with
preventive anti-inflammatory medication (inhaled corticosteroids. cromolyn or nedocromil).
The guidelines also emphasize providing patient education.

The study objectives were a) to determine if the NIH guidelines for the treatment of
childhood asthma were implemented by prescribing preventive medication. b) to determine
if the NIH guidelines for the treatment of childhood asthma were implemented by providing
patient education and c) to measure the influence of primary care physicians prescribing in
accordance with the NIH guidelines on adverse clinical outcomes. Adverse clinical
outcomes were measured by severe asthma exacerbations resulting in: hospital admissions.
emergency department visits or a course of oral steroids from the primary care physicians.

The data were collected from primary-care physicians in nine managed care plans in the
northeastern USA. 311 children enrolled in Medicaid (aged 2-19 years) were identified as
having a diagnosis and treatment for asthma during the period January through December
1994. Detailed clinical and pharmacy data were extracted from medical records by nurse
reviewers forthe period January 1993 through March 1995.

The NIH guidelines for the use of preventive anti-inflammatory medication were
implemented on at least one occasion for 61. l % of the children with moderate or severe
asthma in this Medicaid population during 1994. Patient education was provided to 41.8%
of the children. Cox regression analyses showed prescribing preventive medication for
moderate to severe asthmatics in accordance with the NIH guidelines was associated with a
reduced risk of receiving a course of oral steroids.

The findings of the present study suggest that many children with moderate or severe

(

asthma were not prescribed preventive medication or provided education by primary care
providers as recommended in the NIH guidelines. Inadequate implementation of the NIH
guidelines for prescribing preventive medications was associated with adverse clinical
outcomes.
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PREFACE
This dissertation is organized using the manuscript fo rmat. Part I consists of the three
manuscripts that form the main body of the dissertation. Part 2 contains the appendi ces
which provide the details requ ired by the Uni versity but are not usuall y presented in a
published paper.

Part I includes the following man uscripts:
Study I: Medications prescribed to ast hmatic children:
a historical cohort study of the implementation of NIH recommendati ons

Study 2: Patient education prov ided to asthmatic children:
a hi storical cohort study of the implementation of NIH recommendati ons

Study 3: Divergence from NIH guidelines for pharmacologic therapy and
ri sk of adverse outcomes in asthmatic children: a hi stori cal cohort study

Part 2 includes the following appendices:
Appendix A. Introduction and review of the problem
Appendix B. Details of the methods
Appendix C. Overview of major findings
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PART 1

Part l includes the following manuscripts:
Study 1: Medications prescribed to asthmatic children:
a historical cohort study of the implementation of NIH recommendations

Study 2: Patient education provided to asthmatic children:
a historical cohort study of the implementation of NIH recommendations

Study 3 : Divergence from NIH guidelines for pharmacologic therapy and
risk of adverse outcomes in asthmatic children: a historical cohort study

Medications prescribed to asthmatic children : a historical cohort study of
the implementation of NIH recommendations

ABSTRACT
Background: NIH guidelines recommend treatment of moderate or severe childhood
asthma with preventive anti-inflammatory medication (inhaled corticosteroids. cromolyn or
nedocromil).

Objective: To determine if the NIH guidelines for the treatment of childhood asthma were
implemented by examining the prevalence of prescribing preventive medication. We also
examined clinical and demographic predictors of receiving preventive medication.

Design: Non-concurrent cohort study.

Setting: 9 managed care plans in the northeastern USA.

Subjects: 311 children (aged 2 to 19 years) who were treated for asthma between January
and December 1994.

Main outcome: Prescribing preventive medication.

Results: Preventive medications were prescribed at least once to 61.1 % and more than
once to 27.0% of the children with moderate or severe asthma during 1994. Preventive
medication was prescribed at least once to 27. l % of the children with mild asthma during
1994.

2

Logistic regression analyses indicated that preventive medication was more likely to be
prescribed for those with moderate or severe compared with mild asthma (aOR 5.34. 95%
CI 3.22-8.83) and for older children. (age 5 to 19 years compared with 2 to 4 years. aOR
2.11. 95% CI 1.19-3.72). Prescribing preventive medication was also associated with a
prior emergency department visit (aOR 2.27, 95% CI 1.24-4.16), after adjusting for age.

Conclusions: The NIH recommendations were implemented by prescribing preventive
medication for 66.7% of the moderate or severe asthmatics over 4 years old during 1994.
This study suggests there may be a need for interventions to increase the implementation of
the NIH guidelines by primary care physicians and improve the treatment of childhood
asthma.

3

INTRODUCTION
In 1991 an Expert Panel prepared NIH guidelines for the diagnosis and management of
asthma. ' The Expert Panel updated the recommendations in 1997 and continued to
emphasize the role of inflammation in the pathogenesis of asthma.' The panel outlined an
approach to asthma therapy that has four components : patient education , environmental
control, comprehensive pharmacologic therapy and objective monitoring measures to
monitor the severity of disease and course of therapy.

Daily long term preventive anti-inflammatory medications (such as inhaled corticosteroids,
cromolyn sodium or nedocrornil) are recommended for persistent asthma. 2 Children
consistently requiring symptomatic treatment more than twice a week (classified as
moderate or severe asthmatics) should be given daily anti-inflammatory therapy. In
addition, appropriate medications to manage acute asthma exacerbations (beta-agonists and
oral corticosteroids) should also be prescribed.

This study determines the extent to which the NIH guidelines for the treatment of childhood
asthma were implemented by examining the prevalence of prescribing preventive
medication by primary care physicians. In addition, this study identifies the demographic
characteristics, clinical characteristics or events that are predictors of prescription of
preventive medication to children. Evidence that guidelines influence patient care is needed
because the effectiveness of guidelines in changing practice behaviors and improving health
outcomes is widely questioned.3

4 5
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METHODS
Data source and study population
The data analyzed were from a sample of3 I I children (aged 2 to 19 years) treated for
asthma during 1994 in a Medicaid program in the northeastern USA.

Pharmacy and clinical data were requested from nine managed care plans. Each plan was
requested to identify all Medicaid members who were diagnosed and treated for asthma
during 1994 (International Classification of Diseases, Ninth Revision, Clinical modification
code ICD-9=493) and select a random sample of 50 children (aged 2 to 19 years in 1994)
to study. The plans provided 388 medical records and 347 were eligible after verifying the
patient's age on 1st January 1994 was between 2 to 19 years old (41 were less than 2 years
old). 311 were eligible after confirming there was a visit with documentation of a
prescription foran asthma medication during 1994(36out of347 did not have
documentation of a visit during 1994).

The data abstracted on asthma treatment provided by plan physicians between Ist January
1993 and 3 Ist March 1995 were abstracted from the medical records. Medication data
abstracted included all the asthma medications prescribed (product name, route, directions ,
days supply}, date prescribed and prescriber (primary care physician or other). The clinical
data included the date of each physician visit, an assessment of the asthma severity at each
visit, date of birth, gender, date of initial asthma diagnosis, date of latest theophylline level ,
date of latest influenza vaccination, and types of patient education provided at each visit
(ability to use peak flow meter, ability to use inhaler, how to use inhaler, side effects of
medication, avoidance of triggers, action plan for exacerbations, use of diaries, and goals
of treatment). For each visit there was also a record of height, weight, blood pressure, a
physical examination, medical history (symptoms and functional status), objective
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measures of lung function (peak expiratory flow rates. home use of a peak flow meter.
spirometry results) and referrals to specialists (dates, type of specialist. reason ).

The clinical outcomes extracted from the medical records included asthma-related hospital
admissions or emergency department visits (admission dates, discharge dates and reason
for visit or admission ). A physician visit resulting in the prescription of a course of oral
steroids was also considered as an outcome.

Procedures
A data collection instrument and abstracting instructions were provided to nurses who
reviewed the members· medical records, and hospital or emergency department encounter
files. For each physician visit the nurse reviewer recorded the pharmacy and clinical data
requested, such as asthma severity , patient education and asthma medications prescribed.
The nurse used the information in the medical records and the NIH guidelines to classify
the asthma severity at each visit as mild, moderate or severe asthma.

Statistical analyses
Descriptive statistics were used to document the age, gender, asthma severity, medications
prescribed, and clinical outcomes for the 311 children treated for asthma during 1994.

On each date when asthma medications were prescribed these were coded as beta-agonists
(oral or inhaled), preventive anti-inflammatory medications (inhaled corticosteroids, inhaled
cromolyn or nedocromil) , oral theophylline or oral corticosteroids. The children were
coded as receiving undertreatment at a visit where the disease severity was recorded to be
moderate or severe and no preventive medications were prescribed. The maximum asthma
severity recorded in 1994 was used to code the children as mild, moderate or severe
asthmatics.

6

Preventive medication and undertreatment ever being prescribed during the study were used
as dichotomous dependent variables in bivariate analyses (Mantel-Hanszel chi square tests)
and in multivariate logistic regression. Independent variables in these models included age,
gender, asthma severity, prescribing a course of oral steroids at the same visit or a prior
visit, prior admission to hospital or a prior emergency department visit. Multivari ate
adjusted odds ratio, 95% Wald confidence interval (Cl), Wald chi-square statistic and the
p-value for a two sided significance test were calculated for each independent variable.

Age was coded as a dichotomous variable (2 to 4 years and 5 to 19 years) after establishing
that the associations were not linear for each dependent variable. Asthma severity was
coded categorically as mild ( I), moderate (2), or severe (3). In addition, for the
multivariate model for prediction of prescribing preventive medication, asthma severity was
coded as a dichotomous variable mild (0) and moderate or severe asthma (I).

7

RESULTS

Descriprive and bivaricue analyses
Frequency distributions of demographic characteristics, a~thma severity, medications
prescribed, emergency department visits and hospitalizations are summarized in Tables 1-2.
Moderate or severe asthma was experienced by 49.4% ( 126) of the children, 20.9% (65)
were prescribed oral steroids. 18.7% (58) made an emergency department visit and 6.8%
(2 1) were admitted to a hospital. During 1994. amongst the children with moderate or
severe asthma, 27.0% (2 l) experienced severe asthma exacerbations. 44.4% (56) were
prescribed oral steroids, 28% (35) made an emergency department visit and 11.9% ( 15)
were admitted to a hospital.

During 1994, the overall percentages of children prescribed asthma medications on at least
one occasion were as follows: theophylline 4.8% ( 15), an inhaled steroid 17.7% (55),
cromolyn or nedocromil 27.3% (83) and a beta-agonist 86.5% (269).

Preventive medication (cromolyn, nedocromil or inhaled steroid) was prescribed on at least
one occasion to 61. l % (77) and more than once to 27.0% (34) of the children with
moderate or severe asthma. Preventive medication was prescribed on at least one occasion
during 1994 to 27. l % (35) of the children with mild , 60.9% (56) with moderate and
61.8% (21) with severe asthma (Table I). The results from the bivariate analyses showed
that children were more likely to be prescribed preventive medication if they were aged 5 to
19 years, male, or experienced moderate or severe asthma exacerbations. The results of
this study indicated that the NIH guidelines for the use of preventive medications were
implemented on at least one occasion for 66.7% of the children aged 5 to 19 years old with
moderate or severe asthma during 1994.
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A course of oral steroids at the same or prior visit or a prior emergency department visit
were significantly associated with a subsequent prescription of preventive medication , but a
prior hospital admission was not significantly associated with preventive medications
subsequently being prescribed.

65.9% (83) of the children with moderate or severe asthma were undertreated on at least
one visit when other asthma medications were prescribed (Table 2). 38.9% (49) of the
children with moderate or severe asthma were undertreated on 50% or more visits when
other asthma medications were prescribed. A course of oral steroids was associated with
an increased risk of undertreatment either at the same visit or subsequent visits. A prior
emergency department visit was significantly associated with a reduced risk of
undertreatment at subsequent visits, but a prior hospital admission was not significantly
associated with undertreatment at subsequent visits .

Mulrivariareanalyses
Multivariate odds ratios are presented in Table 3 forthe independent associations between
asthma severity, an oral steroid course and a prior emergency department visit and
prescribing preventive medication , after adjusting for age. The children were significantly
more likely to be prescribed preventive medication if they had moderate or severe
compared to mild asthma exacerbations (aOR 5.34, 95% Cl 3.22-8.83) and were age 5 to
19 years compared to 2 to 4 years old (aOR 2.11, 95% CI 1. 19-3 .72).

The independent associations between prescribing a course of oral steroids or a prior
emergency department visit and subsequently prescribing preventive medications were also
evaluated (without adjusting for asthma severity due to multicollinearity) (Table3). A
course of oral steroids being prescribed at the same or prior visit (aOR 2.79, 95% CI l.574.93) or a prior emergency department visit (aOR 2.27, 95% CI 1.24-4. 16) was associated

9

with prescribing preventive medication, after adjusting for age (Table 3). Gender was not
significantly associated with preventive medication once age and asthma severity were
included in the model.

Multivariate odds ratios for the association between undertreatment of children with
moderate or severe asthma and age, asthma severity, an oral steroid course, a prior
emergency department visit or a prior hospital admission are presented in Table 4.
Moderate compared to severe asthma was not a significant predictor of undertreatment
(Table 4). A prior emergency department visit significantly reduced the risk of subsequent
undertreatment by the primary care physician (aOR 0.24, 95% CI 0.10-0.60) but a course
of oral steroids was associated with an increased risk (aOR 2.23. 95%CI 1.01-4.89) of
undertreatment at the same visit or subsequent visits, after adjusting for age. Age 5 to 19
years compared to 2 to 4 years was associated with less risk of undertreatment on 50% or
more of the visits (aOR 0.44, 95% CI 0. I9- I .02), after adjusting for prior hospitalization,
a prior emergency department visit and an oral steroid course.
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DISCUSSION
Asthma is the most common chronic illness in children and has been studied frequently as
an indicator of the adequacy and appropriateness of ambulatory care. " 7 8 The impact of
asthma on the health of children experiencing moderate or severe asthma in this study was
reOected in the number admitted to a hospital ( 11.9%) or attending the emergency
department (27.8%) during 1994.

The results of this study suggest that the NIH guidelines for the use of preventive
medications were implemented on at least one occasion for 66.7% of the children aged 5 to
19 years old with moderate or severe asthma during 1994, in thi s Medicaid population.
However, amongst children with moderate or severe asthma only 27.0% had more than
one prescription for preventive medication documented in the medical records during 1994.
Amongst the children with moderate or severe asthma, 38.9% were undertreated on 50% or
more physician visits when other asthma medications were prescribed, and 65.9% were
undertreated on at least one occasion. Thus, although the majority of patients with
moderate or severe asthma were prescribed preventive medication at least once during
1994, regular prescribing of preventive medication was not evident. The pattern of
prescribing in this study is not consistent with full implementation of the NIH guidelines,
which support regularly prescribing preventive anti-inflammatory medication to children
with moderate or severe asthma.

The NIH guidelines recommend anti-inOammatory medications but indicate that
theophylline can be prescribed for childhood asthma. Theophylline has a narrow
therapeutic index. For a child over 5 years old who needs maintenance medication, an
inhaled steroid or cromolyn is considered the simplest and safest regimen. 9 Slow-release
theophylline does offer an alternative to inhaled corticosteroids when a patient complies
poorly with a maintenance regimen of inhaled steroids or cromolyn and is judged more
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likely to adhere to an oral regimen. In this study the prevalence of prescribing theophylline
was very low (4.8% ), and cannot therefore account for the apparent undertreatment of
moderate or severe asthmatics with anti -inflammatory products.

The low overall prevalence of prescribing of preventive medications (cromolyn 27.3% and
inhaled steroids 17.7%) and theophylline (4.8%) are comparable with those recorded in
other studies of children in different health care settings. 10

11

Friday et al 9 studied children

treated for asthma in the emergency department and calculated the percentages of children
prescribed asthma medications before the visit were: cromolyn (35%), inhaled steroids
(22%) and theophylline (6%). Donahue et al 10 analyzed the percentage of prescriptions for
privately insured children and found a similar trend: 16% forcromolyn, 11 % inhaled
steroids and 6% theophylline.

The results from three recent studies of children with moderate or severe asthma have also
suggested that the NIH guidelines recommending the use of preventive medication have not
been fully implemented. Eggieston at al "collected questionnaires completed by the
families of 166 asthmatic children requiring an emergency room visit in the past six
months, and found less than 50% were receiving preventive medication. Lieu et al
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studied 508 children hospitalized or attending the emergency department as a result of
severe asthma and 990 asthmatic controls. The study reviewed the medications prescribed
to the children attending a physician within 30 days before either the hospital admission or
emergency department visit and reported up to 49% were prescribed cromolyn or inhaled
steroids. Homer et al 6 found that at most 33% of the children hospitalized for asthma had
received cromolyn or inhaled steroids before admission.

Low rates of repeat prescriptions for preventive medications were also obtained in other
studies, including both adults and children. A study of moderate or severe asthmatics
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(adults and chi ldren over7 years old), showed 63 % were dispensed preventive medications
(but only 32% were receiving preventive medications regularly). Another study' 5 also
suggested less than 54% of the patients (adults and children over 12 years) prescribed anti inflammatory medications were refilling tbe medications regularly. A study of British
children indicated'" very few (less than 15%) were dispensed preventive medications
regularly.

Inadequate attendance for primary care physician follow up visits were shown by a study
in asthmatic children in the Medicaid program in Massachusetts 17 and similarly less
continuous treatment 18 has been noted for asthmatic adults from lower socioeconomic
groups. Focus groups of urban minority asthmatic children in New York 19 showed many
parents and children had very modest expectations of symptom control. Asthma was
viewed by the families as ''episodic" increasing their empbasis on symptomatic treatment
rather than seeing the need for preventive visits. In our study, lack of continuity of care
cannot completely explain the results because 38.9% of the children with moderate or
severe asthma attended the primary care physician more than once and were not prescribed
preventive medications.

We examined five factors associated with prescribing preventive medication, including age ,
asthma severity, a prior emergency department visit or hospital admission or prescribing a
course of oral steroids at the same or prior physician visit. The multivariate and bivariate
analyses suggested that physicians were more likely to prescribe preventive medication for
children aged 5 to 19 years old than younger children with moderate or severe asthma.
These results were consistent with implementation of the NTH guidelines. Children
younger than 5 years of age are recommended to be given courses of oral steroids for
chronic severe asthma because they may be unable to use inhalers effectively.1 Children
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with moderate asthma were at a similar risk to children with severe asthma for
undertreatment, after adjusting for age.

The physicians prescribed preventive medications to the children experiencing acute asthma
exacerbations as indicated by an increased association between an emergency department
visit or a course of oral steroids and subsequent prescribing of preventive medication, after
adjusting for age. Amongst the children with moderate or severe asthma, there was also a
reduced risk of subsequent undertreatment among those with an emergency department
visit, after adjusting for age. However, in contrast, a course of oral steroids, after
adjusting for age, was associated with undertreatment either at the same or subsequent
physician visits. Thus, the prescribing was not consistent with implementing the NIH
guidelines for children attending with moderate or severe asthma: even aftertaking into
account the difficulty of treating children under 5 years old with inhaled medications.

The study design did not include a sample size large enough to allow comparisons between
the different managed care plans or profile the prescribing practices of individual
prescribers. Asthma specialists have been shown to be more likely to prescribe preventive
medications than primary care physicians20 21 and access to or co-ordination of care by
specialists"

23

may have facilitated implementation of the NIH guidelines by some plans.

It was not possible to compare the results from this Medicaid group with other patients

attending these plans. Access to Medicaid for children is generally related to low family
income, therefore this study selected children with a low socioeconomic status. The
infonnation collected from this Medicaid asthmatic population may not be generalizable to
other children. There could be differences in prescribing practices or attendance at the
physician office for preventive care visits by Medicaid patients.

14

In the present study medications were free for the patients; thus there was no cost incentive
for patients to avoid having prescriptions dispensed for preventive medications. The
managed care plans guarantee access for these Medicaid patients but there are many
differences between poor minority families and health care providers that may influence
prescribing practices for example language, cultural barriers, or literacy levels. 19

Hospitalization was not found to be associated with subsequent prescribing of preventive
medications. However, the frequency of hospitalization showed a seasonal variation. This
variation, in combination with the small sample size and the variability of asthma severity ,
may have limited the ability of this study to detect an association.

An unusual aspect of this study was the collection of clinical data from primary care
physician medical records. The asthma diagnoses were confirmed from the medical records
and therefore the study did not have to rely solely on the !CD 9 coding for the diagnosis.
Using the medical records also allowed the classification of children as mild, moderate or
severe asthmatics at each physician visit when an asthma medication was prescribed. The
maximum severity recorded during 1994 was used to code the children as mild, moderate
or severe asthmatics for the entire study period. The analyses were then able to address
confounding by asthma severity. Most previous studies focused on severe asthmatics or
did not use the NIH guidelines to assign a clinical assessment of asthma severity. A
limitation of this study was that the information about medications prescribed was also
collected from the medical records rather than a separate medication claims database;
consequently, not all the prescriptions may have been dispensed or refills may not have
been documented.

There are many challenges to moving patients away from episodic attendance at the primary
care physician's office or emergency department for crisis orientated care and provision of
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fragmented care for asthma exacerbations."" The lack of regular prescribing of
preventive medications for some children in our study may show a need for more patient
education, provider training, and alternative disease management approaches to introduce
26 27 28

asthma prevention strategies.

Studies of the impact of the NIH guidelines on the emergency department management of
childhood asthma have suggested that implementation of the guidelines may be limited. 29 30
Lantneret al 29 surveyed physicians at academic medical centers with a pediatric residency
program and found that at most half of those surveyed believed their emergency
management of asthma was influenced by the NIH guidelines. Crain et al 30 surveyed
physicians based at a sample of children· s emergency departments and found that 45.5%
had heard of the guidelines and 24% had read them. Crain et al also reported under-use of
steroids in the emergency departments and a wide variation in practices.

Preventive medication was prescribed for 66.7% of the moderate or severe asthmatics over
4 years old, which indicates there could be a substantial improvement in the management of
childhood asthma by primary care physicians. Our study suggests that for some children
prescribing of preventive anti -inflammatory medications was subsequent to an emergency
department visit and that the NlH recommendations were not always routinely implemented
by primary care providers for children with moderate or severe asthma. This study
supports the need for interventions to increase implementation of the NIH guidelines by
primary care physicians and improve the treatment of childhood asthma.
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Table l Descriptive statistics and bivariate relationships between
demographic characteristics, asthma severity or prior clinical events and
prescribing of preventive medication, (n=Jll)
Characteristics

Total
n

Total

%

311

Age (years) 2-4

Gender

Preventive medication
prescribed
n

%

121

38.9

92

29.6

27

29.4

5-19

219

70.4

94

42.9

Female

146

47.3

47

32.2

Male

163

52.8

72

44.2

Mild

129

50.6

35

27.I

Moderate

92

36. 1

56

60.9

Severe

34

13.3

21

61.8

.03

.03

Asthma severity

Oral steroid course

0
>=I

Emergency visit

0
> =I

Hospital admission

0
> =I

246

79.1

84

34.2

65

20.9

37

56.9

253

81.4

88

34.8

58

18.7

29

50.0

290

93.3

111

38.3

21

6.8

7

33 .3

18

.00

.00

.03

.65

Table 2 Descriptive statistics and bivariate relationships between demographic characteristics,
asthma severity or prior clinical events and prescribing of preventive medication or
undertreatment for children with moderate or severe asthma, (n=126)
Charnctcri stics

Total
Age (years)

Gender

Total

Preventive mc<lic;.1tion

n

prcscri bell
%
77
6 1.1

%

126

39

31.0

19

48.7

5- 19

87

69. I

58

66.7

Female

54

43.2

29

53.7

Male

71

56.8

47

66.2

Moderate

92

73 .0

56

60.9

Severe

34

27.0

21

61.8

70

55.6

43

61.4

Un<lcrtrcatmcnt 50%

of \•isi ts

"

2-4

Um.J crtre<.1tmcnl

.06

. 16

11

'ii

n

83

65.9

49

%
3K.9

28

71.8

18

46.2

55

63.2

31

35.6

40

74. 1

22

40.7

42

59.2

27

38.0

60

65.2

35

38.0

23

67.7

14

41.2

40

57.I

.35

.08

.27

.76

<O

Severity

Oral steroid
course

Emergency visit

Hospital
admission

()

>= I

56

44.4

34

60.7

0

91

72.2

50

55.0

>= I

35

27.8

23

65.7

111

88. I

68

61.3

15

I 1.9

6

40.0

0
>=I

.93

.94

.28

. 12

43

76.8

61

67.0

13

37.1

70

63.1

6

40.0

.80

.02

.00

.09

25

35.7

25

44.6

40

44.0

9

25.7

41

36.9

5

33.3

.75

.3 1

.06

.79

Table 3 Multivariate adjusted Odds Ratios and 95% confidence intervals
(Cl) for predictors of receiving a prescription for preventive medication,
( n=3 ll )
Characteristics

Preventive medication prescribed

aOR

Cl

Model/:
Moderate or severe

5.34

.00

3.22-8.83

2.11

.01

1.19-3 .72

2.79

.00

1.57-4.93

2.02

.0 1

1.18-3.47

2.27

.01

1.24-4.16

2. 13

.01

1.22-3.70

compared to mild asthma
Age >=5 years

Mode/2:
Prior oral steroid courses
compared with none
Age >=5 years

Mode/3:
Prior emergency department visits
compared with none
Age >=5 years

20

Table 4 Multivariate adjusted Odds Ratios and 95 % confidence intervals

(Cl ) for predictors of undertreatment of children with moderate or severe
asthma, (n=l26)

Characteristics

Undertreatment

Undertreatment >=50% of visits

aOR

p

Cl

aOR

p

Cl

0.24

.00

0.10-0.60

0.30

.02

0.11 -0.79

0.52

.29

0.15-1.75

0.79

.72

0.22-2.80

2.23

.05

1.01 -4.89

2.00

.08

0.91 -4.38

0.74

.48

0.33- 1.70

0.44

.05

0.19-1.02

1.14

.76

0.49-2.65

1.12

.79

0.50-2.50

0.67

.34

0.29- 1.53

0.67

.31

0.31 - 1.45

Model I:

Prior emergency visits
compared with none
Prior hospital admissions
compared with none
Prior oral steroid courses
compared with none
Age >=5 years

Mode/2:

Severe compared to
moderate asthma
Age >=5 years
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Patient education provided to asthmatic children

a historical cohort study

of the implementation of NIH recommendations

ABSTRACT
Background: NIH guidelines for the treatment of childhood asthma emphasize the
importance of educating the patient and their famil y about avoiding triggers and providing
information to support self-management of asthma therapy.

Objective: To determine if the NIH guidelines for the treatment of childhood asthma were
implemented by examining the prevalence of patient education provision by primary care
physicians. We also examined clinical and demographic predictors of providing patient
education.

Design: Non-concurrent cohort study.

Setting: 9 managed care plans in the northeastern USA.

Subjects: 311 children (aged 2 to 19 years) who were treated for asthma between January
and December 1994.

Main outcomes: Patient education on the potential benefits from avoidance of
environmental triggers. Provision ofa written action plan forthe treatment of acute
exacerbations, explaining the goals of treatment and checking the ability to use an inhaler
appropriately.

Results: Patient education was provided at least once to41.8% of the children during
1994. Logistic regression analyses indicated that two predictors of providing information
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about avoidance of triggers were severe compared 10 mild or moderate asthma (aOR 3.61.
95% CI 1.69-7.72) and being prescribed inhaled anti-inilammatory medications (aOR
2.38. 95% CI 1.37-4. 12), after adjusting for age. Inhaled an1i-inilamma1ory medications
were prescribed for 61.1 % of !he children with moderate or severe asthma. and 27. I% of
the children with mild asthma.

Conclusions: The NIH recommendations to provide patient education were not
implemented for at least half of the children during 1994. In addition. less than half of the
children prescribed preventive medications or a course of oral steroids were also provided
infonnation about avoidance of triggers. We conclude therefore that the Iimited
implementation of the NIH recommendations by primary care physicians in our study has
substantially reduced the impact of the NIH guidelines on the management of poorly
controll ed childhood asthma.
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INTRODUCTION
In 1991 an Expert Panel prepared NIH guidelines for the diagnosis and management of
asthma.' The Expert Panel updated the recommendations in 1997 and continued to
emphasize the role of inflammation in the pathogenesis of asthma.' The expert panel
outlined an approach to asthma therapy that has four components : patient education,
environmental control. comprehensive pharmacologic therapy and objective monitoring
measures to monitor the severity of disease and course of therapy.

The guidelines emphasize the importance of patient education in the management of asthma
and the potential benefits from environmental control. The guidelines specifically
recommend provision of action plans, information on avoidance of triggers, goals of
treatment and ability to use an inhaler, use of diaries and side effects of medications.

A written action plan to guide patient self-management is especially important for patients
with moderate or severe persistent asthma and patients with a history of severe
exacerbations. Asthma severity is highly variable and may change over time so assessment
is recommended at least biannually. Routine assessment allows the physician to check that
treatment goals are being met and that the patient is on appropriate pharmacotherapy with
up to date self management and action plans. The ability to use the inhalers correctly
should also be checked to ensure maximum benefit from the medication prescribed,
especially if asthma control is not achieved .

Exposure of an asthmatic patient to inhalant allergens to which the patient is sensitive
increases airway inflammation and symptoms. Substantially reducing such exposure will
result in significantly reduced inflammation, symptoms and need for medication. The NIH
guidelines recommend that patients with asthma at all levels of severity receive education
about the importance of minimizing exposure to inhalant triggers. The counseling should
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include how to control and avoid exposure to known allergens, cigarette smoke and to
make reasonable attempts to reduce exposure to respiratory viruses.

This study determines the extent to which the NlH recommendations have been
implemented by the primary care physicians for children with asthma in a randoml y
selected population of Medicaid patients enrolled in managed care plans. The study
summarizes provision of patient education and information about environmental control. In
addition, the study identifies demographic characteristics, clinical characteristics or events
that are predictors of primary care physicians providing patient education to children.
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METHODS
Data source and study population
The data analyzed were from a sample of 311 children (aged 2 to 19 years) treated for
asthma during 1994 in a Medicaid program in the northeastern USA .

Pharmacy and clinical data were requested from nine managed care plans. Each plan was
requested to identify all Medicaid members who were diagnosed and treated for asthma
during 1994 (International Classification of Diseases, Ninth Revision, Clinical modification
code ICD-9--493) and select a random sample of 50 children (aged 2 to 19 years in 1994)
to study. The plans provided 388 medical records and 347 were eligible after verifying the
patient's age on !st January 1994 was between 2 to 19 years old (41 were less than 2 years
old). 3 l l were eligible after confirming there was a visit with documentation of a
prescription for an asthma medication during 1994 (36 out of 347 did not have
documentation of a visit during 1994).

The data abstracted on asthma treatment provided by plan physicians between Ist January
1993 and 31st March 1995 were abstracted from the medical records. Medication data
abstracted included all the asthma medications prescribed (product name, route, directions,
days supply), date prescribed and prescriber (primary care physician or other). The clinical
data included the date of each physician visit, an assessment of the asthma severity at each
visit, date of birth, gender, date of initial asthma diagnosis, date of latest theophylline level,
date of latest influenza vaccination , and types of patient education provided at each visit
(ability to use peak flow meter, ability to use inhaler, how to use inhaler, side effects of
medication, avoidance of triggers, action plan for exacerbations, use of diaries, and goals
of treatment). For each visit there was also a record of height. weight, blood pressure, a
physical examination, medical history (symptoms and functional status), objective
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measures of lung function (peak expiratory flow rates. home use of a peak flow meter.
spirometry results) and referrals to specialists (dates. type of speciali st, reason).

Cl inical outcomes extracted from the medical records included asthma-related hospital
admissions or emergency department visits (admission dates, discharge dates and reason
for visit or admission). A physician visit resulting in the prescription of a course of oral
steroids was also considered an outcome.

Procedures
A data collection instrument and abstracting instructions were provided to nurses who
reviewed the members ' medical records, and hospital or emergency department encounter
files. For each physician visit the nurse reviewer recorded the pharmacy and clinical data
requested , such as asthma severity, type of patient education provided and asthma
medications prescribed. The nurse used the information in the medical records and the
NlH guidelines to classify the asthma severity at each visit as mild , moderate or severe
asthma. If patient education was provided this was classified by the nurse reviewer in
accordance with the recommendations in the NIH guidelines as providing an action plan for
exacerbations, information on avoidance of triggers, goals of treatment and ability to use
inhaler, medication side effects or use of diaries to record asthma exacerbations.

Statistical analyses
Descriptive statistics were used to document the age, gender, asthma severity. medications
prescribed , clinical outcomes and the type of patient education provided for the 3 I I
children treated for asthma during 1994.

On each date when patient education was provided the four types of information were
coded as provision of an action plan. information on avoidance of triggers, goals of
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treatment and ability to use the inhaler. On each date when asthma medications were
prescribed these were coded as beta-agonists (oral or inhaled) , preventive antiinflammatory medications (inhaled corticosteroids, inhaled cromolyn or nedocromil), oral
theophylline or oral corticosteroids.

Each type of education was used as dichotomous dependent variables in bivariate analyses
(Mantel-Haenszel chi square tests) and in multivariate logistic regression models.
Independent variables in these models included age, gender, asthma severity, prescribing
preventive medication or a course of oral steroids at the same visit or a prior visit, prior
admission to hospital or a prior emergency department visit. Multivariate adjusted odds
ratio, 95% Wald confidence interval (Cl), Wald chi-square statistic and the p-value for a
two sided significance test were calculated for each independent variable. The Bonferroni
correction was used to calculate the appropriate significance level forthe p-values
(p=<O.O 125).

Age was coded as a dichotomous variable (2 to 4 years and 5 to 19 years) after establishing
that the associations were not linear for each dependent variable. The maximum asthma
severity recorded in 1994 was used to code the children as mild, moderate or severe
asthmatics. For the multivariate analyses, the categories of asthma severity were collapsed ,
as appropriate, according to the associations found for each type of education.
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RESULTS
Descriptive and bivariareana/vses

The rel ationships between provi sion of patient education and demographi c characteri stics,
asthma severity, medications prescribed, emergency department visits and hospitalizations
are summarized in Tables 1-2. The Bonferroni correction was used to calculate the
appropriate significance level for the p-values (p=<O.O125).

Patient education was documented for less than 50% of the children during 1994,
regardless of the type of education. Specifically, action plans were provided on at least one
occasion to 41 .8% ( 130) of the children during 1994. Information on the importance of
avoiding triggers was provided to 24.4% (76) of the children. Limited patient education
was provided to support self-management of asthma by using the medications prescribed
appropriately; 13.5% (42) of the children received information on the goals of the treatment
and 15.8% (49) had their ability to use the inhaler checked.

Applying the criteria in NIH guidelines for asthma severity classified 50.6% ( 129) as mild
asthmatics, 36. I% (92) experienced at least one moderate and 13.3% (34) at least one
severe asthma exacerbation during 1994. Action plans were provided to 76.5% (26) of the
children with severe asthma, 55.4% (51) with moderate asthma and 40.3 % (52) with mild
asthma. Information on avoidance of tri ggers was provided to 52.9% ( 18) of the children
with severe asthma, 29.4% (27) with moderate asthma and 233 % (30) with mild asthma.
Bivariate analyses showed that children with moderate or severe asthma were more
frequently provided an action plan for exacerbations, and information on avoidance of
triggers or goals of treatment.

Fewer than 25% of the children with moderate or severe asthma were documented in the
medical records as being provided either: information on the goals of treatment or having
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the ability to use the inhaler correctly confirmed. Fewer than 10% of children with
moderate or severe asthma were provided information about medication side effects or used
diaries. However, children prescribed a course of oral steroids were significantly more
likely to be provided two types of patient education at the same or subsequent visits :
information on avoidance of triggers (p-value =0.003) or a review of the treatment goals
(p-value=0.01).

Prescribing preventive medications was associated with providing three types of patient
education. Preventive anti-inflammatory medication (inhaled corticosteroids, cromolyn or
nedocromil) were prescribed by the primary care provider for 38.9% ( 121) of the children.
The children prescribed preventive medication , were significantly more frequently provided
three types of patient education : goals of treatment (p-value=0.001 ), action plan (pvalue=0.001), and avoidance of triggers (p-value=0.001). Prescribing preventive
medication was not significantly associated with confirmation of the ability to use an
inhaler.

Adverse clinical events were not associated with subsequent provision of patient education
by the primary care providers. Bivariate analyses did not show either emergency
department visits or hospitalization to be significantly associated with subsequent provision
of patient education.

Multivariate analyses
Multivariate odds ratios for the association between receiving four types of patient
education and asthma severity, preventive medication, and age are presented as Model 1
(Table 3). Multivariate odds ratios for the independent associations between an oral steroid
course (Model 2), or an emergency department visit (Model 3) and the four types of patient
education provided are presented in Table 3. The associations between hospitalizations and
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provision of patient education were not estimated using multivariate analyses because of the
small number of children admitted to hospital. The Bonferroni correction was used to
calculate the appropriate significance level for the p-values (p=<0.0125).

Multivariate analyses showed that asthma severity was significantly associated with the
provision of three types of patient education: an action plan , information on avoidance of
triggers and a review of treatment goals (after adjusting for age and prescribing preventive
medication) (Table 3). The adjusted odds ratios for an action plan for exacerbations were
as follows: moderate compared to mild asthma aOR 1.85 (95% CI 1.25-2.75), and severe
compared to mild asthma aOR 3.43 (95% CI 2.32-5.09). The adjusted odds ratio for
provision of information on avoidance of triggers to children with severe asthma compared
to mild or moderate asthma was aOR 3.61 (95% CI 1.69-7 .72). The adjusted odds ratio for
a review of the treatment goals for moderate or severe compared to mild asthma was aOR
3.12 (95% CI 1.45-6.72).

Associations between prescribing preventive medications and providing patient education
are presented in Table3. Children prescribed preventive medication were significantly
more likely to receive two types of patient education at subsequent visits (after adjusting for
age and asthma severity) : avoidance of triggers (aOR 2.38, 95% CJ 1.37-4.12), and a
review of the treatment goals (aOR 3.14, 95% CI 1.46-6.75) but not ability to use an
inhaler. Children prescribed a course of oral steroids were also significantly more likely to
be provided two types of patient education at the same or subsequent visits (after adjusting
for age): avoidance of triggers (aOR 2.62, 95% Cl 1.43-4.77) and a review of the
treatment goals (aOR 2.63 , 95% Cl 1.29-5.36).
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Emergency department visits were not associated with the subsequent provision of patient
education by the primary care providers. A prior emergency department visit was not a
significant predictors (after adjusting for age) for primary care providers subsequently
providing an action plan (aOR 0.79, 95% CI 0.42- 1.49), information about avoidance of
triggers ( aOR 0.84. 95% CI 0.39- 1.80), a review of treatment goals (aOR 2.49, 95%CI
1.11-5.55), or confirming the ability to use an inhaler (aOR 1.21 , 95% CI 0.54-2.74).
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DISCUSSION
The NIH guidelines recommend that all asthmatic children receive education about asthma
and avoidance of triggers. However, provision of patient education was not documented in
the medical records for the majority of children in our study. Action plans for severe
exacerbations were the most frequent form of patient education provided and were given to
41.8% of the children . Action plans were provided to the majority of children with
moderate (55.4%) or severe asthma (76.5% ). Multi variate analyses showed that asthma
severity was significantly associated with provision of three types of patient education.
However, fewer than 25% of the children with moderate or severe asthma were
documented in the medical records as being provided either information on the goals of
treatment or having the ability to use the inhaler correctly. Less than 10% of children with
moderate or severe asthma were provided information about medication side effects or use
of diaries.

Preventive medication was prescribed for61.1% of the children with moderate or severe
asthma and 27.1 % of the children with mild asthma. Children who were prescribed
preventive medication were more likely to be provided information about avoidance of
triggers aOR 2.38 (95% CI 1.37-4.12), or education about treatment goals aOR 3. I4 (95%
CI 1.46-6.75), after adjusting for age and asthma severity. 39.9% of children with
moderate or severe asthma were not prescribed preventive medication and were also less
likely to receive information about the importance of avoiding triggers or education about
asthma. There was no significant association between a prior emergency department visit or
hospitalization and patient education being provided by the primary care providers.

This study indicates a need for more patient education, provider training, and new
approaches to ensure widespread implementation of the NIH recommendations by primary
care providers. 3

4 5

Other studies of the impact of the NIH guidelines on the emergency
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department management of childhood asthma have also suggested that implementation of
the guidelines may be limited." 7

The study design did not include a sample size large enough to allow comparisons between
the different managed care plans or profile the prescribing practices of individual
prescribers. Asthma specialists prescribe preventive medications more frequently than
primary care physicians8 9 and access to or co-ordination of care by specialists 10

11

may

have facilitated implementation of the NIH guidelines by some of the plans.

This population-based study of Medicaid el igible children is restricted to children from low
income families. It was not possible to compare the results from this Medicaid group with
other patients attending these plans. The present study suggests there is limited
implementation of the NIH recommendations even for a group known to be at particularly
high risk of asthma-related hospitalization 1' or mortality. 13

1
"

The NlH guidelines advocate providing education to the patients and their family but there
are some conflicting results about the effectiveness of providing very limited education to
patients. One systematic review and meta-analysis of the published literature on adults
concluded that limited asthma education (information only) for adults reduced emergency
department visits and improved knowledge but did not reduce hospitalizations or physician

visits. 15

One limitation of our study was the use of medical records to evaluate patient education as
the quality of the education routinely provided cou ld not be assessed. The extent of the
education provided may also have been underestimated; for example the ability to use an
inhaler may be checked by pharmacists and not recorded in the medical records. In
addition , education may be provided to the patient but not documented in the medical
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records by the health care provider. This study may have underestimated the amount of
patient education provided, which could have biased the estimates of the associations
towards the null value.

The potential impact of providing appropriate patient education for children has been
demonstrated.

16

A randomized control trial studied the impact over 12 months of an initial

training program comprising five 1 hour sessions for the parents and children. This study
found an increase in knowledge, compliance and reduced emergency room visits and days
of hospitalization.

Poor knowledge about asthma will make self-management difficult and lack of parental
knowledge has been associated with readmission to hospital
department visits.'

0 21

17 18 19

or emergency

For example, if the patients start or increase steroid medication at the

onset of a cold or flu this has been shown to reduce the odds of an emergency department
visit." There is also evidence to suggest that co-operation between health care providers,
parents and children is essential to achieve optimal management. 23

Patient education was documented for less than half of the children during 1994, regardless
of the type of education. The findings of the present study suggest that provision of patient
education by primary care providers was associated with asthma severity. However, less
than a quarter of the children with moderate or severe asthma were documented in the
medical records as being provided information on the goals of treatment or having the
ability to use the inhaler correctly confirmed. In addition, over half of the children
prescribed inhaled anti-inflammatory medication were not provided information about
avoidance of triggers. Poorly controlled asthma is estimated to account for approximately
30% of the direct medical costs of asthma24 and also results in many social costs to the
children and their family , for example by causing absenteesim from school." Nearly two
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thirds of the ambulatory care visits for asthma are to primary care providers ratherthan
asthma specialists.' 6 We conclude therefore that the limited implementation of the NIH
recommendations by primary care physicians in our study has substantially reduced the
impact of the NIH guidelines on the management of poorly controlled childhood asthma.

40

ACKNOWLEDGMENTS
We would like to thank Harry Sterling, Janice Griffin and Fortuna Kostelac for their
contributions to this project. This study was supported in part by funding from the United
Healthcare Corporation.

41

Table 1 Descriptive statistics and bivariate relationships between
demographic characteristics, asthma severity, prior clinical events or
medication prescribed and providing action plans or advice on avoidance
of triggers
Characteristics

Total
n

Total

%

311

Action plan for
exacerbations

Avoidance of

n

%

n

130

41.8

76 24.4

triggers
%

Age (years)

2-4

92

29.6

31

33.7

5-19

219

70.4

99

45.2

Gender

Female

146

47.3

60

41.1

Male

163

52.8

70

42.9

Mild

129

50.6

52

40.3

Moderate

92

36.1

51

55.4

27 29.4

Severe

34

13.3

26

76.5

18 52.9

190

6 l.l

59

31.1

>= I

121

38.9

71

58.7

0

246

79.1

95

38.6

65

20.9

35

53.9

253

81.4

97

38.3

58

18.7

17

29.3

290

93 .3

122

42. l

21

6.8

5

23.8

.06

.74

15

16.3

61

27.9

32 21.9

.03

.30

44 27.0

Asthma severity

Preventive medication

Oral steroi d course

0

>=I
Emergency visit

0

>=I
Hospital admission

0

>=I

Bonfcrroni test for significance p-value=<O.O l'.!5

42

.00

.00

30 23.3

32

16.8

.00

.00

44 36.4

.03

51

20.7

.00

25 38.5
.20

57 22.5
JO

.LO

17.2

70 24.J
2

.38

9.5

.13

Table 2 Descriptive statistics and bh•ariate relationships between
demographic characteristics, asthma severity, prior clinical events or
medication prescribed and reviewing the treatment goals or ability to
use an inhaler
Characteristics

Total
n

Goals of
treatment
%

n

%

Ability to use
inhaler

p

n

%

49

15.8

16

17.4

15.5

33

15.I

16

11.0

.20 21

14.4

52.8

26

16.0

28

17.2

50.6

II

8.5

18

13.6

Moderate 92

36. 1

22

23 .9

23

25.0

Severe

34

13.3

8

23.5

7

20.6

0

190

61.1

12

6.3

>=I

121

38.9

30

24.8

0

246

79.l

27

11.0

65

20.9

15

253

81.4

58

Total

311

Age (years)

Gender

42

13.5

2-4

92

29.6

8

8.7

5- 19

219

70.4

34

Female

146

47.3

Male

163

Mild

129

.II

p

.61

.50

Asthma severity

Preventive medication

Oral steroid course

>=I
Emergency visit

0
>= I

Hospital admission

0
>=I

.00

.00 23

12.l

26

21.5

35

14.2

23.I

14

21.5

27

10.7

.08 33

13.0

18.7

II

19.0

290

93 .3

36

12.4

21

6.8

3

14.3

Bonferroni test for significance J>-Value=<D.0 125

43

.01

9
.80 47

. 12

.03

.15

.62

15.5
16.2
4.8

. 16

Table 3 Multivariate adjusted Odds Ratios and 95 % confidence intervals (Cl) for the association
between asthma severity, age, prescribing prenntive medication and receiving patient education
Chamctcri stics

A \'(1i Uancc c1f triggers

Act ion plan

e

Cl

aOR

e

aOR

1.88

.02

1.09-3.24

2.38

.00*

1.37-4. 12

3. 14

Severity

1.85'

.00*

1.25-2.75

3.61'

.00*

1.69-7.72

3. 12

Age >=5 years

1.77

.05

1.00-3. 16

1.8 1

.08

0.94-3.48

Oral steroid <..-oursc

1.97

.02

1. 13-3.45

2.62

.(XI*

A gc >=5 years

1.73

.04

1.03 -2.89

2.20

Emergency visi t

0.79

.47

0.42- 1.49

Age >=5 years

2.22

.0 1*

1.27-3.88

Preventive medi cation

Abil ity tu use inhaler

T rCJ lmC'n l goals

Cl

aOR

e

Cl

aOR

e

Cl

.00*

1.46-6.75

1.49

.25

0.76-2.93

.00*

1.45-6.72

2.35

.0 1*

1.20-4.6 1

1.78

. 19

0.76-4. 18

0.81

.54

0.41-1.59

1.43-4.77

2 .63

.0 1*

1.29-5.36

1.64

. 17

0.82 -3.27

.02

1.1 6-4. 19

2. 13

.07

0.93-4.88

0.88

.M>

0.45- 1.<>9

0.84

.66

0.39-1.80

2.49

,()3

1.11 -5.55

1.21

.64

0.54-2.74

2. 18

.03

1.09-4.33

2.99

.02

1.1 7-7.65

0.96

.9 1

0.47-1.97

Model I:

""'""'

c

c

Model 2:

Model 3:

Asthm a severity code: 'O=Mi ld l=Mcxlemte 2= Severe '<>=Mil <l & mcxlemle I= Severe 'O=Mi l<l l=Mndera le & severe
*Bonfcrroni tes t for sign ificance p-value=<O.O 125
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4B

Divergence from NIH guidelines for pharmacologic therapy and risk of
adverse outcomes in asthmatic children : a historical cohort study

ABSTRACT

Objective: To determine if the implementation of NIH guidelines for the treatment of
moderate or severe childhood asthma with preventive anti-inflammatory medication
(inhaled corticosteroids, cromolyn or nedocromil ) reduced the risk of severe asthma
exacerbations.

Design: Non-concurrent cohort study.

Setting: 9 Medicaid managed care plans in the northeastern USA.

Subjects: 311 children (aged 2-19 years) who were treated for asthma during the period
January 1993 to December 1994.

Main outcomes: Admission to hospital , emergency department visit or a course of oral
corticosteroids.

Results: Cox regression analyses were conducted with time dependent covariates for
being prescribed preventive medications and adjusting for asthma severity (mild, moderate
or severe), with a fixed covariate for age. Children diagnosed with moderate or severe
asthma at least once who were prescribed preventive medication were less likely to require
a course of oral steroids (Hazard Ratio 0.42 95% Cl 0.19-0.95), after adjusting for age and
asthma severity. No significant association was found between prescribing preventive
medications and hospital admission or an emergency department visit.
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Conclusions: Prescribing preventive medication to children with moderate or severe
asthma reduced the risk of exacerbations requiring a course of oral steroids. This study
suggests that primary care physicians prescribing anti -inflammatory medication in
accordance with the NIH guidelines may improve the clinical outcomes for children with
moderate or severe asthma.
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INTRODUCTION
Asthma is the most common chronic childhood illness in the US 1 affecting 6.9% of
children and is the fourth leading cause of disability in children.' In 1991 an Expert Panel
prepared NIH guidelines for the diagnosis and management of asthma.3 The Expert Panel
recommendations were updated in 1997 and continued to emphasize the role of
inflammation in the pathogenesis of asthma.' The panel outlined an approach to asthma
therapy that has four components: patient education, environmental control. comprehensive
pharmacologic therapy and objective monitoring of the asthma severity.

Daily long term preventive anti-inflammatory medications (such as inhaled corticosteroids,
cromolyn sodium or nedocromil ) are recommended by the NIH guidelines for persistent
asthma . Children consistently requiring symptomatic treatment more than twice a week
(classified as moderate or severe asthmatics) should be given daily anti-inflammatory
therapy. In addition , appropriate medications to manage acute asthma exacerbations (betaagonists and oral corticosteroids) should also be prescribed.

Primary care physicians have multiple opportunities to implement the NIH guidelines, to
monitor asthma severity, and adjust the pharmacotherapy. This study determined whether
the implementation of NIH guidelines for the treatment of moderate or severe childhood
asthma by primary care physicians prescribing preventive anti-inflammatory medication
(i nhaled corticosteroids, cromolyn or nedocromil) reduced the risk of severe asthma
exacerbations. Severe asthma exacerbations were measured by a hospital admission ,
emergency department visit or a course of oral steroids from the primary care physician.
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METHODS
Data source and study population
The data analyzed were from a sample of 311 children (aged 2- 19 years) treated for asthma
during 1994 in a Medicaid program in the northeastern USA.

Medication and clinical data were requested from 9 managed care plans. Each plan was
requested to identify all Medicaid members who were diagnosed and treated for asthma
during 1994 (International Classification of Diseases, Ninth Revision, Clinical modification
code ICD-9---493), and select a random sample of .SO children (aged 2 to 19 years in 1994)
for study. The plans provided 388 medical records and 347 were eligible after verifying
the patient's age on I st January 1994 was between 2 to 19 years old (41 were less than 2
years old). 311 were eligible after confirming there was a visit with documentation of a
prescription for an asthma medication during 1994 (36 out of 347 did not have
documentation of a visit during 1994).

The data on asthma treatment provided by plan primary care physicians between I st
January 1993 and 31st March 1995 were abstracted from the medical records. Medication
data abstracted included all the asthma medications prescribed (product name, route,
directions, days supply), date prescribed and prescriber (primary care physician or other).
The clinical data included the date of each physician visit, an assessment of the asthma
severity at each visit, date of birth, gender, date of initi al asthma diagnosis, date of latest
theophylline level, date of latest influenza vaccination, and types of patient education
provided at each visit (ability to use peak flow meter, ability to use inhaler, how to use
inhaler, side effects of medication, avoidance of triggers, action plan for exacerbations, use
of diaries, and goals of treatment). For each visit there was also a record of height, weight,
blood pressure, a physical examination , medical history (symptoms and functional status),
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objective measures of lung function (peak expiratory flow rates, home use of a peak flow
meter, spirometry results) and referrals to specialists {dates, type of specialist, reason).

The clinical outcomes extracted from the medical records included asthma-related hospital
admissions or emergency department visits (admission dates, discharge dates and reason
for visit or admission). A primary care physician visit resulting in the prescription of a
course of oral steroids was also considered.

Procedures
A data collection instrument and abstracting instructions were provided to nurses who
reviewed the members' medical records, and hospital or emergency department encounter
files. For each primary care physician visit the nurse reviewer abstracted the data
requested, such as asthma severity, patient education and asthma medications prescribed.
The nurse used the information in the medical records and the NIH guidelines to classify
the asthma severity at each physician visit as mild , moderate or severe asthma. According
to the clinical characteristics described in the NIH guidelines, mild asthmatics have
infrequent, mild exacerbations which can be up to twice a week which are generally of
brief duration. Moderate asthmatics have symptoms twice or more per week, the
exacerbations may last several days and occasionally require emergency care. Severe
asthmatics have continuous symptoms, limited activity levels, frequent nocturnal
symptoms, and occasional hospitalization and emergency treatment.

Asthma severity was coded as mild ( 1), moderate (2) or severe (3) at each physician visit.
The maximum asthma severity recorded before the first event of the outcome under
evaluation was used to divide the children into mild, moderate and severe asthmatics.
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Asthma medications were coded as beta-agonists (oral or inhaled). preventive antiinflammatory medications (inhaled corticosteroids, inhaled cromolyn or nedocromil), oral
theophylline or oral corticosteroids. The children were coded as receiving undertreatment
at a visit where the asthma severity was moderate or severe and no preventive medications
were prescribed.

Prescribing anti-inflammatory medications in accordance with the NIH guidelines was
determined by the following dichotomous variables: preventive medication (prescribed at
least once), preventive medication prescribed at 50% or more of the visits when other
asthma medications were prescribed, undertreatment (preventive medication was not
prescribed at least once when the children visited the primary care physician with moderate
or severe asthma) or undertreatment at 50% or more of the visits when other asthma
medications were prescribed.

The age on Ist January 1994 was calculated and coded in four categories (2 to 4 years, 5 to
7 years, 8 to 11 years and 12 to 19 years). In addition the multivariate analyses included
age coded as two dichotomous variables. After establishing that the associations were not
Ii near for each outcome, age was coded as 2 to 4 years and 5 to 19 years for an emergency
department visit and a course of oral steroids or 2 to 7 years and 8 to 19 years for a hospital
admission.

The seasons were coded as a dichotomous variable for each physician visit. The fall-winter
season was coded as I st October to 31st March.

For the descriptive analyses the beginning of person-time for an individual was defined as
the date of the first physician visit when an asthma medication was prescribed between I st
January 1993 and 31st December 1994. The end of person-time was defined as the first
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date forthe outcome under evaluation afterthe first physician visit (either a hospital
admission or an emergency department visit for asthma or a course of oral steroids) or the
end of the study period (3 I st December I994). Person-time and events after the first event
of the outcome under evaluation were therefore censored and not evaluated.
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STATISTICAL ANALYSES
Descriptive statistics and bivariate analyses
Descriptive statistics were used to document the age, gender, asthma severity. medications
prescribed and clinical outcomes for these 31 l children treated for asthma during 1994.

Emergency deparrment visirs, hospiral admissions or course of oral sreroids

Hospital admission, emergency department visit or course of oral steroids per person-year
were calculated and documented by the following independent variables: age group, gender
and asthma severity before the outcome under evaluation. The incidence density ratio
(!DR) was calculated for each age group relative to the 2 to 4 year olds. The !DR were
calculated for each asthma severity relative to the mild asthmatics.

ln addition the bivariate relationship was evaluated between the event rates and prescribing
preventive medication to children with moderate or severe asthma before each outcome.
The !DR were calculated for each outcome relative to the children that received no
preventive medication or no undertreatment.

Prevenrive medicarionand underrrearmenr

Preventive medication and undertreatment (for moderate and severe asthmatics) per personyear were calculated and documented by the following independent variables: age group,
gender and asthma severity before each outcome. The incidence density ratio (!DR) was
calculated for each age group relative to the 2 to 4 year olds. The !DR were calculated for
each asthma severity relative to the mild asthmatics for preventive medication and moderate
asthmatics for undertreatment. For each outcome children were identified who had a visit
with moderate or severe asthma before the event. The !DR were calculated relative to the
chi ldren that had no event for each outcome.
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Multivariate analyses
For each outcome, Cox's regression method' was used to determine adjusted hazard ratios
and 95% confidence intervals (Cl) for exposure to preventive medication or
undertreatment, both when coded as fixed covariates or as time-dependent covariates.

The fixed covariates were exposure to preventive medication or undertreatment, or a fixed
covariate for exposure to preventive medication or undertreatment at the last visit in the
study or before the event as appropriate. The fixed covariate analyses selected children
with moderate or severe asthma before the outcome and used the time from the first visit
when asthma medication was prescribed to the event or 31st December 1994.

The analyses also included time dependent covariates for preventive medication ,
undertreatment, asthma severity (mild= I, moderate=2 or severe=3), and season. The time
dependent analyses used the time from the first visit with moderate or severe asthma when
asthma medication was prescribed to the event or 3 lst December 1994.

Multivariate adjusted hazard ratios and 95% confidence intervals (CI) were calculated for
each clinical outcome. The analyses all included a fixed covariate for age.
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RESULTS
Descriptive and bivariate results
Emergency deparrment visits, hospital admission or course of oral steroids

Frequency distributions of demographic characteristics, asthma severity, medications
prescribed, emergency department visits, hospital admissions and a course of oral steroids
are summarized in Tables 1-2.

Emergency department visits were made at a rate of 0.260 per person-year, with a
significantly higher rate for children with severe compared to mild asthma (0.573 per
person-year) and for children aged 2 to 4 years when compared to older age categories
(0.437 per person-year). The results from the bivariate analyses showed that children were
more likely to make an emergency department visit if they were aged 2 to 4 years (Table I)
or experiencing severe compared to mild asthma exacerbations (!DR 2.2 95% Cl I .2-3 .9,
p-value 0.00).

Hospital admissions were at a rate of 0.094 per person-year and did not change
significantly with disease severity or decreasing age group.

Oral steroid courses were prescribed to children with severe asthma exacerbations at a rate
of 0.217 per person-year and the rates did not significantly differ between mild or moderate
asthmatics. Oral steroid courses were prescribed at a significantly higher rate to children
aged 8 to l l years old (!DR l.8 95% Cl l.l-3.5, p-value 0.04).

Prescribing preventive medication to children with moderate or severe asthma was
associated with a significantly reduced risk of being prescribed a course of oral steroids,
(!DR 0.4 95% Cl 0.2-0.7, p-value 0.00) (Figure 1, Table 2). The rates were also reduced
although not significantly for hospital admissions, (!DR 0.5 95% CI 0.2- 1.2, p-va lue
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0.06) and emergency depanment visits (!DR 0.7 95% Cl 0.4-1.4. p-value 0. 17), (Figure
l , Table 2).

Undenreatment at 50% or more of the visits was associated with a significantly increased
rate of prescribing a course of oral steroids (!DR 2.6 95% Cl 1.0-6.4, p-value 0.02)
(Table 2). Undenreatment was not associated with significantly increased emergency
department visit rates or hospital admission rates (Figure 2, Table 2). Gender was
uniformly not a significant predictor of the clinical outcomes.

Preventive medical ion and undertreatment

Preventive medication was prescribed at a rate of0.828 per person-year to the children with
severe asthma, 0.614 per person-year to the children with moderate asthma and 0.270 of
the children with mild asthma (Table 3). The results from the bivariate analyses showed
that moderate or severe asthma exacerbations before each outcome were significant
predictors of preventive medication being prescribed (Table 3). Moderate asthmatics were
not significantly more likely to be undertreated than severe asthmatics (Table 4). Gender
and age were not significant predictors of prescribing preventive medication or
undertreatment (Tables 3-4).

The preventive medication prescribing rates for children with moderate or severe asthma
before the event were not significantly lower before an emergency depanment visit,
hospitalization or a course of oral steroids (Table 5). The analyses suggest that there was
significantly more undertreatment amongst children with moderate or severe asthma before
an emergency department visit (!DR 1.8 95% Cl 1.2-2.8, p-value 0.01 ) or a course of oral
steroids (!DR 2.6 95% Cl l.6-4.3 , p-value 0.00) but not before hospitalization (Figure 3,
Table 5).
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Multivariate analyses
Hazard Ratios (HR) for the association between preventive medication and an emergency
department visit, hospital admi ssion or a course of oral steroids for children with moderate
or severe asthma are presented in Table 6.

Prescribing preventive medication to children with moderate or severe asthma was
associated with a significantly reduced risk of a course of oral steroids in both a) the fixed
covariate analyses for prescribing preventive medication at the last visit before the event
(HR 0.26 95% Cl 0.09-0.77, p-value 0.02), after adjusting for age and b) the time
dependent covariate analyses for prescribing preventive medication (HR 0.42 95% Cl
0.19-0.95, p-value 0.04), after adjusting for age and asthma severity (Figure 4).

Prescribing preventive medication was not associated with a significantly reduced risk of an
emergency department visit after adjusting for age, asthma severity and an interaction with
season. Periods of moderate or severe asthma were associated with a significantly higher
risk for an emergency department visit (moderate asthma HR 1.96, 95% Cr 1.11 -3.47, and
severe asthma HR 3.86 95% Cr 2.88-5. 16, p-value 0.03, after adjusting for age and
preventive medication).

A course of oral steroids (unadjusted HR 2.4, 95% Cr 1.3-4.4, p-value 0.0 I) and asthma
severity (unadjusted HR 2.1, 95% Cl 1.2-3.7, p-value 0.01) when coded as timedependent covariates, were also associated with a significantly increased risk of an
emergency department visit.

The multivariate analyses of children with moderate or severe asthma indicated a
significantly increased risk of an emergency department visit or a course of oral steroids
with undertreatment (Table 7). Undertreatment was associated with a significantly
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increased risk of a course of oral steroids in both a) the fixed covariate analyses for
undertreatment at the last visit priorto an event if one occurred (HR 5.0 I, 95% Cl 1.9912.65. p-value 0.00), after adjusti ng for age and b) the time dependent covariate analyses
(HR 2.53 , 95% Cl 1 15-5.58, p-value 0.02), after adjusting for age and asthma severity
(Figure 5).

Undertreatment was associated with a significant ly increased risk of an emergency
department visit in the fixed covariate analyses for undertreatment at the last visit prior to an
event if one occurred (HR 2.08, 95% CI 1.03-4.20, p-value 0.04). The time dependent
analyses showed asthma severity was associated with an increased risk for an emergency
department visit (moderate asthma HR 2.12. 95% CI 1.20-3.72, and severe asthma HR
4.48. 95% CI 3.36-5.97, p-value 0.01 after adjusting for age and undertreatment).

No significant results were obtained for an association between prescribing preventive
medication and reducing the risk of hospital admission (Table 6). There was an increased
but not significant association between undertreatment at the last visit prior to an event if
one occurred and hospitalization (HR 2.45, 95% CI 0.91 -6.62, p-value 0.08) (Table 7).
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DISCUSSION
(

The results of this study suggest that the NIH guidelines for the use of preventive
medications were implemented by the primary care physicians on at least one occasion to
39.9% of the children in this study. Amongst the children with moderate or severe asthma
during this study, 65.4% were not prescribed preventive medication on at least one
occasion when they attended the primary care physician with moderate or severe asthma.
The pattern of prescribing in this study is not consistent with full implementation of NIH
guidelines, which support regularly prescribing preventive anti -inflammatory medication to
children with moderate or severe asthma.

This study shows that prescribing preventive medications by primary care physicians in
accordance with NIH guidelines was associated with improved clinical outcomes in this
study population. Severe asthma exacerbations requiring treatment with a course of oral
steroids were reduced by more than half amongst the children prescribed preventive
medication HR 0.42 (95% CI 0.19-0.95) (Figure 4 ). Multivariate analyses also showed
that there was 2.5 times the risk of a subsequent course of oral steroids, among those with
undertreatment (Figure 5). Undertreatment at the last primary care physician visit before an
emergency department visit or a course of oral steroids was also associated with a
significantly increased risk of both these adverse outcomes.

Undertreatment on at least one primary care physician visit was approximately twice as
common in children attending the primary care physician with moderate or severe disease
before an emergency department visit or before receiving a course of oral steroids (Figure
3). This study did not show a significant association between undertreatment and either a
hospital admission or an emergency department visit (Figures 2 and 5). This study did
however indicate that the primary care physicians could be prescribing preventive
medications to more of the moderate or severe asthmatics. The high rates of emergency
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department visits. hospital admissions and courses of oral steroids showed the impact of
severe asthma exacerbations on the health of these children. Undertreatment is a modifiable
risk factor for acute asthma exacerbations that could be successfully changed by the
primary care physicians fully implementing the NIH guidelines.

Other studies of asthmatic children have reported more under-use of preventive medication.
A study was conducted by Kaiser Permanente Medical Care Program in California of
children hospitalized or attending the emergency department as a result of severe asthma
between January-July 1995. The study reviewed the medications prescribed to children
attending a physician within 30 days of the hospital admission or emergency department
visit: over 73% were prescribed a beta-agonist, 47% a course of oral steroids but only up to
49% were prescribed cromolyn or inhaled steroids.• Under-use of preventive medications
was also found amongst asthmatic children (48% were Medicaid patients) attending the
emergency department of an inner city academic pediatric hospital in Pennsylvania during
1994: 35% were previously ever prescribed cromolyn and 22% ever prescribed inhaled
steroids. 7 A questionnaire completed by the families of392 asthmatic children living in the
inner city, revealed that only 11 % were receiving preventive medication. Selecting 166
children with more severe asthma exacerbations requirin g an emergency room visit in the
past six months, the authors found that even in 1992 over 50% were under-treated and
were not receiving preventive medication.•

The results from the current study are also consistent with two studies using claims data
bases which supported the suggestion that inhaled corticosteroid therapy caused a
significant reduction in health care service use by asthmatic children, including Medicaid
enrollees. One study reported asthma medication claims data from 6035 insured (nonMedicaid) asthmatic children, the study was published by a New England based health
maintenance organization, Harvard Pilgrim Health Care (HPHC). The HPHC results
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showed the percentage of asthma prescriptions dispensed for preventive medications
between October 1991 and September 1994 was respectively as follows: beta-agonisrs
67%, cromolyn 16% and inhaled steroids 11 %. theophylline 6%! The study by HPHC
demonstrated that preventive medications confer significant protection against exacerbations
of asthma leading to hospitalization, but did not investigate other clinical outcomes.

A retrospective case-control study of asthmatic Medicaid children (less than 12years old)
used a North Carolina claims database to follow the health care costs of85 cases and 72
controls for I year. 10

11

The cases began inhaled corticosteroid therapy between March

1994 to 1995. The controls were on asthma therapy other than steroids for a continuous 2year period between March 1993 to March 1996. The study demonstrated that tbe
introduction of inhaled corticosteroid therapy to Medicaid children was associated with a
significant reduction in the total health care costs (hospitalizations, physician visits,
outpatient visirs and the cost of medications).

Many of the drugs for asthma can appear to increase risk of adverse outcomes because the
patients for whom asthma medications are prescribed may have an increased risk of
frequent and severe asthma exacerbations." The benefits of prescribing preventive
medication were not always evident in the current study ifthe analyses did not adjust for
asthma severity. Consequently to address confounding by asthma severity, the multivariate
analyses used Cox regression which provided flexibility in the way the asthma severity and
preventive medication were coded. The analyses could select the chi ldren attending with
either moderate or severe asthma before the outcome and include severity as a time
dependent covariate. The Cox regression analyses used both fixed covariates and time
dependent covariates to measure exposure to preventive medication or undertreatment of
children with moderate or severe asthma before each event. Cox regression also allowed
the models to include time dependent variables recorded at irregular intervals for preventive
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medication and severity recorded before the outcome being evaluated.

The observed confidence intervals for associations were often wide because the sample of
patients with a moderate or severe asthma before the emergency department visit or hospital
admission was small. In the bivariate analyses emergency department visit rates were
much hi gher in the group with outbreaks of severe disease. There were about 40 chi ldren
in our sample classified as experiencing severe exacerbations and 56 that received a course
of oral steroids and this therefore limited our analyses.

A course of oral steroids is recommended by the NIH guidelines for the acute treatment of
severe asthma exacerbations and therefore may have compensated for the risk of adverse
outcomes from undertreatment with inhaled anti-inflammatory medication . For example,
one study showed starting or increasing steroid medications at the onset of a cold or flu
reduced the odds of asthmatic children making an emergency department visit. 6 Emergency
department visits were shown in our multivariate analyses to be consistently associated
with prior severe asthma exacerbations or a course of oral steroids. If a course of oral
steroids is considered a surrogate marker for an exacerbation of asthma severity, as
preventive medication reduces the number of severe exacerbations there may also be a
substantially greater potential to reduce emergency department visits than has been evident
in this small sample.

In our study emergency department visits were more common amongst 2 to 4 year olds.
The NJH guidelines recognize this age group is less likely to be able to successfully coordinate inhaling preventive medication, and may have to rely instead on courses of oral
steroids for acute exacerbations. The 0 to 4 year age group bas been found to exhibit
hi gher hospitalization rates for asthma than other age groups"

14

and there is an association

between children aged 2 to 4 years old making more emergency department visits. 15
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16

Hospital admission was less common than an emergency department visit and the rates
appear not to be associated with severity, thus in this small sample the children were not
always attending the primary care physician with moderate or severe disease before being
admitted. The complexity of asthma risk factors may have prevented the association
between undertreatment and admissions to hospital being detected in this sample size and
duration. The triggers for each patient may be different and asthma severity fluctuates,
there may be many periods when although preventive medication is not prescribed the
asthma severity may not deteriorate to require an emergency department visit or
hospitalization. In addition, ifthe children are taken to the physician with severe asthma a
course of oral steroids will in many instances prevent hospitalization or an emergency
department visit being necessary . Hospital admissions in this study were also seasonal
(zero between July and September) and this may also explain the lack of association with
undertreatment in this study.

One predisposing factor for emergency department visits or hospital admissions seems to
be the season of the year as more events were recorded during fall or winter. Similar
results have also been recorded in other studies and viral infections have been suggested as
a possible explanation for these seasonal trends." Viral infections aggravate clinical
asthma and increase airway responsiveness that may persist for weeks after the infection. 18
For example, two studies on asthmatic children reported the most common symptom
experienced prior to the emergency department visit was wheezing induced by respiratory
infections (over75%). 7

19

In our study, the reasons for the emergency department visits

and hospital admissions were not recorded in detail. For example, it was not known
whether a viral infection was considered the trigger forthe acute exacerbation or an indoor
allergen.
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The information collected from chis Medicaid asthmatic population may not be generalizable
to other children. There could be differences in prescribing practices or attendance at the
physician office for preventive care visits by Medicaid patients. The managed care plans
guarantee access for these Medicaid patients but there are many differences between poor
minority families and health care providers that may influence prescribing practices for
example language, cultural barriers, or literacy levels-'° Asthma may be viewed by families
as ··episodic" rather than needing regular attendance at the physician for preventive
medications. The study design did not include a sample size large enough to allow
comparisons between the prescribing practices and outcomes from each of the nine
different managed care plans or profile individual primary care prescribers.

The race of the chi ldren in the current study was not known but it is possible some of the
minority children are under-utilizing the primary care physicians. Studies of Medicaid
asthmatic children have showed that African-American children have significantly fewer
primary care physician visits than their white counterparts even after adjusting for potential
confounding variables, suggesting under-use of preventive services for asthma ."

22

A

racial disparity may therefore exist in access to effective management of chronic asthma.

Indoor allergens, such as cockroaches as well as dust mites or pets are now recognized as
important triggers, which may be important amongst children living in poor housing
conditionsn It was not known whether these children were living in inner city homes or
rural conditions.

A disproportionate number of poor children have been shown to rely on the emergency
department instead of primary care providers for their asthma care. 7 2 2 24 Higher
hospitalization rates for asthma have been recorded for poor or minority children."

26

For

example, a study of hospital discharge data from asthmatics less than 25 years old showed
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that black patients were five times more likely than white to be hospitalized for asthma and
50% more likely to be readmitted. 27 These patient and various health care system
characteristics all pose challenges to Medicaid patients moving away from episodic
attendance at the primary care physician ·s office or emergency department for crisis
orientated. fragmented care for asthma exacerbations.' 1 28

29 30

Rates for asthma prevalence are highest among children residing in inner cities and
important risk factors for asthma-related mortality includes being poor or black.'

31

"

33

The Medicaid eligibility criteria for this study means all the children were from poor
families. It was not possible to compare the results from this Medicaid group with other
patients attending these plans. In the present study medications were free for the patients:
thus there was no cost incentive for patients to avoid having prescriptions dispensed for
preventive medications. In addition, a study of asthmatic Medicaid recipients showed that
trends in prescribing anti-inflammatory medications were consistent and parallel with
changes observed in the general population.3 4 However, two cross-sectional studies of
medication claims data have shown an association between underuse of inhaled steroids
and lower income.35 36 This population based study of Medicaid eligible children provides
valuable information about the effectiveness of the NIH recommendations in a sample from
the group of children known to be at a high risk of adverse outcomes.

An unusual aspect of this study was the collection of clinical data from primary care
physician medical records. The asthma diagnoses were confirmed from the medical
records and therefore the study did not have to rely solely on the ICD 9 coding for the
diagnosis. In the past the diagnosis criteria have varied for classifying asthma severity but
the NlH guidelines include a working definition of mild, moderate and severe asthma
severity. Access to the medical records allowed the NIH guidelines to be used to classify
the children as mild, moderate or severe asthmatics at each physician visit when an asthma
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medication was prescribed. The analyses were then able to address confounding by asthma
severity by stratified analyses and including a time dependent covariate for asthma severity
in the model. Most previous studies focused on severe asthmatics or did not use either the
NIH criteria or a clinical assessment of severity. relying instead on medication claims data
to calculate beta-agonist use rates of children treated by primary care physicians.

The information about prescribing medications was collected from the medical records
rather than a separate medication claims database, consequently not all the prescriptions
may have been actually dispensed or administered regularly as directed. Patient compliance
is important for preventive medications to be beneficial and for children it may be especially
complex as parents, school nurses and other carers may have to administer the medication.
Many studies have identified poor compliance with preventive medication amongst
preschool 37and school children 3 8 as well as with adult asthmatics.39 40 Patient compliance
was not measured in this study, therefore these data may underestimate the value of
prescribing preventive medication to these children.

The low socioeconomic status of these children means they might be unable to avoid some
environmental triggers, have a higher frequency of severe asthma, and experience a lack of
continuity of care more than insured children. The effectiveness of prescribing in
accordance with the NIH guidelines was still however clearly demonstrated as preventive
medication significantly reduced, and undertreatment of moderate or severe asthma
significantly increased the risk of prescribing a course of oral steroids.

Asthma is the most common chronic illness in children 13 and is the most frequent cause of
hospitalization among children41 and one of the leading causes of absenteeism from
school.42 Mortality rates are low for asthma but poorly controlled asthma results in many
social costs to the children in addition to the medical costs associated with high rates of
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physician consultations and hospital admissions. This population-based study supports the
effectiveness of prescribing preventive anti-inflammatory medication under conditions of
actual use by a Medicaid population. This study shows that primary care physicians can
improve the control of asthma by implementing the NIH guidelines and regularly
prescribing anti-inflammatory medication for moderate or severe asthma.
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undertreatment and clinical outcomes for
children with moderate or severe asthma
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Figure 3 Bivariate relationship between clinical
outcomes and undertreatment of children
visiting the primary care physician with
moderate or severe asthma before the event

Emergency
visit

Hospital
admission

Clin ical

Oral steroid
course

- 95% Cl

• IDR

outcome

180
::~

160

~ ~

g

140

~ 120

~ ~ 100
£
c:

~

80

Eg

Go

~

40

.:~

~

::>

D No event

~

)(

O Eveit

20

0
Erner gency

HasPtal

Q"al sterdd

visit

actnissirn

cwrse

Clinical

73

outcome

Figure 4 Adjusted Hazard Ratios (aHR) for
preventive medication and clinical outcomes
for children with moderate or severe asthma
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undertreatment and clinical outcomes for
children with moderate or severe asthma
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Table I Descriptive statistics and bivariate relationships between demographic characteristics, asthma severity
and clinical outcomes
ID = Incidence Density x 10 2 (person-years)
Charnctcri stics

Emergency department

n (person-

c

ID

-.J
Ol

Oml steroids course

IDR
(95% CI)

p

n (person-

c

ID

26

c

ID

9.4

n (personi ·ears)
3 11 (257.97)

56

21.7

92(H2.33)

16

19.4

.'.!9

82(69. 18)

15

2 1. 7

.09

76(54.25)

19

35.0

.09

6 1(52.2 1)

6

11 .5

146( 11 8. 10)

24

20.3

163( 138. 11 )

31

22.5

151( 122.93)

21

17. 1

. 15

105(92.6 1)

24

25.9

. 19

3 1(27.36)

2

7.3

Total

31 1(254.03)

66

26.0

vcars)
3 11 (277.83)

Age '.!-4 yea rs

92(70.98)

31

43.7

92(82.59)

II

13.3

5-7 years

82(72.49)

14

19.3

.<Xl

82(77.65)

8

10.3

.00

76(64.83)

4

6.2

.04

6 1(52.77)

3

5.7

146( 125.82)

13

10.3

163( 149.42)

13

8.7

136( 11 4. 13)

8

7 .0

.06

11 3( 106.65)

12

11 .3

.IXJ

44(43 .72)

5

11.4

8- 11 years

76(6 1.46)

9

14.6

12- 19 years

6 1(49.09)

12

24.4

Female

146( I 18.25)

28

23.7

Male

163( 133.19)

38

28.5

Mild

144( 11 0.80)

29

26.2

MotJ cr~1t c

108(99.40)

16

16. I

40(31.40)

18

57.3

C=Cases

Hospital admission

\'i Si L

~ears)

IDR=lncidence Density Ratio

0.4
(0.2-0.8)
0.3
(0.2-0.6)
0.6
(0.3- 1.1 )

IDR
(95\l Cl)

0.8
(0.4- 1.8)
0.5
(0.2- 1.4)
0.4
(0. 1- 1.5)

p

I DR
(95% CI)

I. I
(0.5-2.4)
1. 8
( 1.1 -3.5)
0.6
(0.2- 1.5)

.38
.04
. 13

Gender

1. 2
(0.8- 1.9)

.23

0 .9
(0.4- 1.8)

.33

I.I
(0.6- 1.9)

.36

1.5
(0.1! -2.7)
0 .4
(0.2- 1.2)

.08

Ast hma sc' crity

SC \' CfC

0.6
(0.3- 1.1 )
2.2
(1.2-3.9)

1. 6
(0.7-3.9)
1.6
(0.5-4.9)

. 12

Table 2 Descriptive statistics and bivariate relationships between preventive medication or undertreatmcnt and
clinical outcomes for children with moderate or severe asthma
ID = Incidence Density x IO' (person -years)
Characteristics

Emcrgcni.;y department visit

c

ID

T otal

n ( person'cars)
148( 130.8)

34

6 1(5 1.1 2)

16

IDR=Incidence Density Ratio

C=Cases

Hospita l admission

Oral steroids course

n (pe rson·cars)

c

ID

26.0

157( 150.4)

17

I 1.3

31.3

58(52.58)

9

17.1

. 17

991,97.79)

8

8.2

.28

73(70.24)

6

8.5

52(45.52)

5

11. 0

IDR

p

IDR

p

n (pe rson'cars)

c

ID

136( 120.0)

26

2 1.7

IDR

p

0.4
(0.2 -0.7)
0.4
(0.2-0.9)

.<Kl

Preventi ve

medication
-.../

No
Yes

87(79.68)

18

22.6

>=.50% ,·isits

64(55.43)

14

25.3

47(39.46)

10

25.3

10 1(91.35)

24

26.3

LO

.46

105( 104.85)

12

11 .4

29.6

(05-2.2)
1.2
(0.5-2.6)

.35

56(55.6 1)

6

10.8

-.../

0.7
(0.4-1.4)
0.8
(0.4-1.7)

0.5
(0.2- 1.2 )
0.5
(0.2- 1.4)

54(38.75)

15

38.7

.06

82(8 1.22)

11

13.5

.09

67(62.83)

10

15.9

47(44. 13)

6

13.6

.47

89(75.84)

20

26.4

.49

56(45.88)

16

34.9

.Il l

Unt.lcru·eatmcnt

No
Yes

>=50% visits

60(50.69)

15

1. 0
(0.4-2.7)
1.0
(0.3-3.7)

1.9
(0.8-4.8)

.07

2.6

.()'.!

( 1.0-6.4)

Table 3 Descriptive statistics and bivariate relationships between
demographic characteristics or asthma severity before the event and
preventive medication
ID=Incidence Density x 10' (person-years) IDR=Incidence Density Ratio
Characteristics

n (person-years)

Cases

ID

311 (257.97)

124

48.I

2-4 years

92 (82.33)

32

38.9

5-7 years

82(69.18)

34

8- 11 years

76 (54.25)

12-19 years

IDR

p

49.2

1.3 (0.8-2. I)

. 17

30

55.3

1.4 (0.9-2.3)

.08

61 (52.2 1)

28

53.6

1.4 (0. 1- 1.7)

.I I

146(118.10)

50

42.3

163 ( 138. 11 )

72

52.I

1.2 (0.9-1.8)

.13

Mild

144 ( 110.80)

30

27 .1

Moderate

108 (99.40)

61

61.4

2.3 ( 1.5-3.5)

.00

40 (3 1.40)

26

82.8

3.1 ( 1.9-5.0)

.00

136 ( 150.37)

31

20.6

113 ( 106.65)

69

64.7

3.1 (2. 1-4.7)

.00

44(43.72)

30

68.6

3.3 (2. 1-5.3)

.00

Mild

151 ( 122.93)

36

29.3

Moderate

105 (92.61)

60

64.8

2.2 ( 1.5-3.3)

.00

3 1 (27.36)

22

80.4

2.7 ( 1.7-4.6)

.00

Total*
Age*

Preventive medication

Gender* Female
Male
Emergency visit

Severe
Hospital admission
Mild
Moderate
Severe
Oral steroids course

Severe

*Calculated before oral steroids course
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Table 4 Descriptive statistics and bivariate relationships between
demographic characteristics or asthma severity before the event and
undertreatment for children with moderate or severe asthma
ID = Incidence Density x IO' (person-years)
IDR= Incidence Density Ratio
Characteristics

Undertreatment
n (person-years)

Cases

ID

136 (119.98)

89

74.2

2-4 years

44 (41.72)

32

76.7

5-7 years

34 (27.71)

21

8-1 lyears

30 (26.87)

12-19 years

IDR

p

75.8

1.0 (0.6-1.7)

.48

21

78.2

1.0 (0.6-1.9)

.48

28 (23 .66)

15

63.4

0.8 (0.4-1.6)

.30

Female

61 (53.52)

42

78.5

Male

74 (65.56)

47

71.7

0.9 (0.6-1.4)

.33

Moderate

108 (99.40)

74

74.5

Severe

40 (31.40)

27

86.0

1.2 (0.8-1.8)

.26

1.0 (0.7-1.5)

.46

0.9 (0.5-1.4)

.28

Total*
Age*

Gender*

Emergency visit

Hospital admission
Moderate
Severe

113 (106.65)

75

70.3

44 (43.72)

30

68.6

105 (92.6 1)

71

76.7

31 (27.36)

18

65.8

Oral steroids course
Moderate
Severe

*Calculated before oral steroids course
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Table 5 Descriptive statistics and bivariate relationships between an emergency department visit, hospital
admission or course of oral steroids and preventive medication or undertreatment of children visiting the
primary care physician with moderate or severe asthma before the event
ID = Incidence Density x 10' (person-years)

IDR= Incidence Density Ratio

Preventi ve medicati on

Characteristics
n (person-

Cases

ID

IDR

Undertrealrnent
p

Cases

ID

IDR

p

1.8 ( 1.2-2.8)

.01

1.3 (0.7-2.4)

. 19

2.6 ( 1.6-4.3)

.00

years)
Emergency visit
CXl
0

No

114 ( 111 .59)

69

61. 8

Yes

34 ( 19.21 )

18

93.7

No

140 ( 104.07)

91

87.4

Yes

17 ( 10.30)

8

77.7

No

110 ( 108.08)

71

65.7

Yes

26( 11.88)

II

92.6

1.5 (0.9-2.6)

.06

77

69.0

24

124.9

93

89.4
11 6.5

Hospital admi ssion

0.9 (0.4- 1.8)

.38

12

69

63.8

1.4 (0.8-2.7)

. 14

20

168.4

Oral steroids course

"

Table 6 Hazard Ratios (HR ) and 95 % Confidence Intervals (C l ) describing the association between
preventive medication and an emergency department visit, hospital admission or course of oral ste roids for
children with moderate or severe asthma
Variable

Emergency department \'isit

Or.i i steroids course

HR

p

CI

HR

p

Cl

HR

0

CI

1.83

. 14

0.82-4.06

3.40

. 10

0.78- 14.97

1.71

.34

0.56-5.22

Age*

0.42

.01

0.21 -0.84

0 .61

.32

0.22- 1.64

0 .66

.38

0.27- 1.65

Pre' cntivc medication a t his t visi t

1.34

.40

0.68-2.65

0.63

.36

0.'.!3- 1.70

0 .'.!6

.O'.!

o.m-o.77

0.44

.02

0.'.!'.!-0.86

0.63

.36

0.'.!3- 1.70

0.83

.69

0.34-2.(14

Prc\'cntivc mcllicuti on prior to C\'Cnt**

1.31

.44

0.66-2.6 1

0.93

.89

0.33-'.!.64

0.4'.!

.!14

0. 19-0.95

Sc\'crit y* * Moderate

1.96

.02

1.11 -3.47

1.02

.99

0.45-2.3'.!

I. II

.74

060-'.!07

3.86

.0'.!

'.!.88-5. 16

0.59

. 15

0.29- 1.22

0.55

.'.!8

0. 19- 1.6 1

1.32

.52

0.57-3.07

Preventive medication

CD

Hospital admi ssion

before c,·cnt
Age*

SC\CfC

Age*

* Age-coding: >=5 years for emergency oepariment visits and ora l steroids & >=8 yea rs for hospi tal admissions
**Ti me dependent covariate

Table 7 Hazard Ratios (HR) and 95 % Confidence Intervals (Cl) describing the associations between
undertreatment and an emergency department visit, hospital admission or a course of oral slcroids for
children with moderate or severe asthma
Variable

Undertrcatmcnt
Age*

Emergency department visi t

Hospital admission

Oral s teroids course

HR

p

Cl

HR

p

Cl

HR

p

Cl

1.1 5

.73

0.52-2.55

1.1 0

.87

0.36-3.38

8 . 13

.04

1.09-60.79

0.46

.02

0.23-0.90

0.63

.37

0.23-1.7 1

0.79

.60

0.32- 1.93
1.99- 1:!.65

CXl
I\)

2.08

.04

1.03 -4.20

2.45

.08

0.9 1-6.62

5.0 1

.(XJ

0.54

.09

0.21- 1.m

0.72

.53

0.26- 1. 99

0.82

.66

0.33-2.!Xl

0.75

.42

0.36- 1. 53

1. 27

.68

0.42-3. 84

2.53

.02

1.1 5-5.58

Moderate

2.12

.0 1

1. 20-3.72

0.94

.90

0.38-2.32

0.76

.47

0.37-1.59

Sc"crc

4.48

.0 1

3.36-5.97

Age*

0.59

. 15

0.29- 1.22

0.56

.28

0. 19- 1.63

1.33

.5 1

0.57-3.09

U ndcrt rcatmcnt at last vi sit before even t

Age*

Undcrtrc<.i uncnt prior toc,·cnt**
Severi ty**

* Age coding: >=5 years for emergency department visits and oral steroids & >=8 years for hospital admissions
**Time dependent covariate
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PART2

Part 2 incl udes the following appendices:
Appendix A. Introduction and review of the problem
Appendix B. Details of the methods
Appendix C. Overview of major findi ngs
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APPENDIX A

INTRODUCTION AND REVIEW OF THE PROBLEM

(

CffiLDHOOD ASTHMA
Studies of childhood asthma indicate a prevalence range of between 0.5 to 6.3% in the
USA.' Asthma is the fourth leading cause of disability' and the most common chronic
disease of childhood.' Mortality rates are low for asthma but poorly controlled asthma
results in many social costs to the children in addition to the medical costs. 4 For example,
asthma is one of the leading causes of absenteeism from school : a loss of more than 10
million school days was estimated for 1990, resulting in lost productivity costs for the
caregivers of $726 million.' Asthma is the most frequent cause of hospitalization among
children and over the last 20 years pediatric hospitalization rates for asthma doubled."
Asthma also leads to high rates of primary care physician consultations and emergency
room visits.5 According to the 1988 National Health Interview Survey (N I-IIS) in a sample
of children less than 18 years old, asthma was rated as severe, moderate and mild for 10%,
32% and 59% of the children. 7 However, the children with severe asthma account for
27% of the days missed from school, 35% of the hospitalizations and 77% of the days in
hospital. 7

Rates for asthma prevalence are highest among children residing in inner cities and
important risk factors for asthma-related mortality include being poor or black. 8

9 10

Higher

hospitalization rates for asthma have also been recorded for poor or minority children. 7

11

For example , a study of hospital discharge data from asthmatics less than 25 years old
showed that black patients were five times more likely than white to be hospitalized for
asthma and 50% more likely to be readmitted. 12 Studies of Medicaid asthmatic children
have shown that African-American children have significantly fewer primary care physician
visits than their white counterparts, even after adjusting for potential confounding
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variables. suggesting under-use of preventive services for asthma. 13

14

A racial disparity

may therefore exist in access to effective management of chronic asthma.

A disproportionate number of poor children have been shown to rely on the emergency
department instead of primary care providers for their asthma care. 141 5

28

Many aspects of

poverty may be increasing the risk of mortality , such as: Jack of access to high quality
health care. Jack of continuity of care, decreased use of anti-inflammatory medications.
housing with high levels of cockroach or dust mite antigens, poor systems of social
support, and low education Jevels. 10

16

Both patient and various health care system

characteristics all pose challenges to moving low income patients away from episodic
attendance at the primary care physician ' s office or emergency department for crisis
orientated, fragmented care for asthma exacerbations. "

17 18 19

The inner city in the US is

inhabited by impoverished people who are disproportionately nonwhite so separating these
risks has proved difficult, however some evidence currently suggests socioeconomic status
is the more important risk factor than race for asthma morbidity. 10

Studies of the prevalence of childhood asthma have shown that the prevalence of asthma
changes during childhood with age and gender.' The prevalence of asthma is higher in
boys Jess than 5 years old, with the distribution becoming more equal later in childhood ,
and among adults asthma is more common in women than men w

21

Amongst children

with mild episodic asthma up to 60% will have an improvement in symptoms by
adulthood, although less than 20% of chronic asthmatics will become asymptomatic. 22

The management of chronic asthma has changed in recent years with the increased
recognition of the important role of the inflammatory component in the pathogenesis of
asthma. The management of asthma currently includes both drug therapy and the
avoidance of known allergens, monitoring Jung function with peak flow meters and a
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greater emphasis on the importance of educating the patient and their famil y about asthma."
Indoor allergens. such as cockroaches, dust mites. pets or cigarette smoke are now
recognized as important triggers for asthma.'"

25

Viral infections aggravate clinical asthma and increase airway responsiveness that may
persist for weeks after the infection." ' 6 Consequently there are seasonal increases in the
frequency of asthma attacks when the epidemic respiratory virus infections are in the
community in the fall or when there are higher concentrations of airborne allergens. For
example. studies on asthmatic children reported the most common symptom experienced
prior to the emergency department visit was wheezing induced by respiratory infections
(over 75%)27

28

and starting or increasing steroid medication at the onset of a cold or flu

have been shown to reduce the odds of an emergency department visit. '°

Research indicates approximately 30% of the direct medical costs of asthma are attributable
to inadequately controlled disease.3° Nearly two thirds of ambulatory care visits for asthma
do not involve asthma specialists but physicians from family medicine or general practice,
pediatrics or internal medicine. 5 Opportunities exist to optimize the treatment of asthma by
primary care physicians and improve the patients quality of life, minimize the impact of the
disease on the family and reduce the frequency and severity of acute exacerbations leading
to hospitalization or emergency room visits.
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NIH GUIDELINES FOR THE TREATMENT OF CHILDHOOD ASTHMA
Summary of recommendations
In 1991 an Expen Panel prepared NIH guidelines for the diagnosis and management of
asthma. 23 The ex pen panel outlined an approach to asthma therapy that has four
components: patient education. environmental control, comprehensive pharmacologic
therapy and objective monitoring measures to monitor the severity of disease and course of
therapy. The Expen Panel updated the recommendations in I997 and continued to
emphasize the role of inflammation in the pathogenesis of asthma. 31 The guidelines issued
in 1997 advocated a stepwise approach, linking asthma severity with treatment alternatives
and put an even stronger emphasis on anti-inflammatory medication .

The NIH guidelines issued in 1991 defined three categories of asthma severity: mild ,
moderate or severe (Table I). The NIH classification of asthma severity is based on
severity before optimal therapy is initiated. Asthma is highly variable, so the characteristics
of each class are general and may overlap plus individuals can switch between categories
over time. The updated guidelines issued in 1997 expanded the categories to four by
dividing mild asthmatics into patients witb mild intermittent asthma or mild persistent
asthma. The data extracted from the medical records related to the period between I993
and I994 therefore this study used the criteria published in I99 l to categorize the asthma
severity and assess the appropriateness of the therapy prescribed.

Daily long term preventive anti -inflammatory medications (such as inhaled corticosteroids,
cromolyn sodium or nedocromil) are recommended for persistent asthma. 23 Children
consistently requiring symptomatic treatment more than twice a week (classified as
moderate or severe asthmatics) should be given daily anti-inflammatory therapy. In
addition, appropriate medications to manage acute asthma exacerbations (beta-agonists and
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oral corticosteroids) should also be prescribed. The treatment recommended by the 1991
guidelines can be summarized as follows:

Mild asthma:
Beta-agonise alone
Cromol yn alone
Beta-agonise and cromolyn

Moderate asthma: Anti-inflammatory agents and bronchodilators
Beta-agonist and inhaled steroid
Beta-agonist, cromolyn and inhaled steroid
Beta-agonist and theophyiline

Severe asthma:
As for moderate asthma with addition oi orai steroids and spacer device.

The NlH guidelines recommend anti-inflammatory medications but indicate that
theophyiiine can be prescribed for childhood asthma. Theophylline has a narrow
therapeutic index so for a chi id over 5 years oid who needs maintenance medication, an
inhaled steroid or cromolyn is considered the simplest and safest regimen." Slow-release
theophylline does offer an alternative to inhaled corticosteroids when a patient complies
poorly with a maintenance regimen oi inhaled steroids or cromoiyn and is judged more
likely to adhere to an oral regimen. The NlH guidelines recognize the younger age group is
less likely to be able to successfully co-ordinate inhaling preventive medication, and may
have to rely instead on courses oi orai steroids for acute exacerbations.
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Oral steroids are very effective anti-inflammatory medications but are reserved for severe
asthma because of the risk of suppressing pituitary adrenal function and causing iatrogenic
Cushings syndrome with the associated impairment of growth. bone formation and bone
density. There is evidence to suggest that children receiving oral therapy also benefit from
inhaled steroids-" The regular prophylactic use of inhaled steroids is the recommended
therapy for moderate asthma, reducing the extent to which theophylline and oral steroids
are prescribed. 33

"

There is substantial evidence to show that moderate doses of inhaled

steroids do not impair growth and maturation because there is such a weak systemic
effect. 35

Beta-agonist medications have been associated with controversy over whether high use was
associated with an increased risk of fatal asthma. There have been numerous headlines
about whether beta-agonists are associated with an increase in asthma deaths, however a
full review of the evidence did not eventually support the initial concems.3 6 The studies
concluded that the increased risk of fatal ornear fatal asthma was clinically important for
adult patients who used > 1-2 cans of inhaler per month37 or for hospitalization for children
using >8 inhalers per person-year. 38 There is also evidence that in patients with mild
asthma. neither deleterious nor beneficial effects derive from regular use of inhaled
albuterol beyond those derived from use of the drug as needed. 39

The guidelines also emphasize the importance of patient education in the management of
asthma and the potential benefits from environmental control. The guidelines recommend
provision of action plans, information on avoidance of triggers, goals of treatment and
ability to use an inhaler, use of diaries and side effects of medications.

A written action plan to guide patient self-management is especially important for patients
with moderate or severe persistent asthma and any with a history of severe exacerbations.
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Asthma severity is highly variable and may change over time so assessment is
recommended at least biannually. This allows the physician to check that treatment goals
are being met and that the patient is on appropriate pharmacotherapy with up to date self
management and action plans. The ability to use the inhalers correctly should also be
checked to ensure maximum benefit from the medication prescribed, especially if asthma
control is not achieved.

Exposure of an asthmatic patient to inhalant allergens to which the patient is sensitive
increases airway inflammation and symptoms. Substantially reducing such exposure will
result in significantly reduced inflammation , symptoms and need for medication. Patients
with asthma at all levels of severity are recommended in the NIH guidelines to receive
education about the importance of minimizing exposure to inhalant triggers. The
counseling should include how to control and avoid exposure to known allergens, cigarette
smoke and to make reasonable attempts to reduce exposure to respiratory viruses.

Implementation of recommendations for childhood asthma
This study determines the extent to which the NlH recommendations have been
implemented by the primary care physicians for children with asthma in a randomly
selected population of Medicaid patients. The study summarizes prescribing of preventive
medication, provision of patient education and information about environmental control. In
addition the study identifies the demographic characteristics, clinical characteristics or
events that are predictors of prescription of preventive medication or provision of patient
education to children.

Primary care physicians have multiple opportunities to implement the NIH guidelines and
optimize the treatment by monitoring the asthma severity, pharmacotherapy and providing
counseling on self-management of asthma. Evidence that guidelines influence patient care
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is needed because their effectiveness in changing practice behavi ors and improving health
outcomes is widely questioned. "'° 41

42

Physician performance has been shown lo be

improved by providing feedback on prescribing practice patterns which can also be used to
support quality improvement initiatives targeting potential areas for change." -1-1

The impact of the guidelines on clinical outcomes will depend on the effectiveness of the
treatment recommended but also on the dissemination of the recommendations from the
specialists to the primary care physicians. For example. asthma specialists have been
shown to be more likely to prescribe preventive medications than primary care physicians4 5
46

and access to or co-ordination of care by specialists"'"" may facilitate implementation of

the NIH guidelines.

The results from four recent studies focused on children with moderate or severe asthma
have indicated that the NIH guidelines recommending the use of preventive medication
have not been fully implemented. A study was conducted by Kaiser Permanente Medical
Care Program in California of children hospitalized or attending the emergency department
as a result of severe asthma between January through July 1995. The study reviewed the
medications prescribed to children attending a physician within 30 days of the hospital
admission or emergency department visit: over 73% were prescribed a beta-agonist, 47% a
course of oral steroids but only up to 49% were prescribed cromolyn or inhaled steroids_,.

Under-use of preventive medications was also found amongst asthmatic children (48%
were Medicaid patients) attending the emergency department of an inner city academic
pediatric hospital in Pennsylvania during 1994: 35% were previously ever prescribed
cromolyn and 22% ever prescribed inhaled steroids. 28 Similarly, a study of children
hospitalized as a result of an asthma exacerbation found that at most 33% of the children
hospitalized for asthma had received cromolyn or inhaled steroids before admission. 49
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A questionnaire completed by the families of392 asthmatic children living in the inner city,
revealed that only 11 % were receiving preventive medication. Selecting 166 children with
more severe asthma exacerbations requiring an emergency room visit in the past six
months, the authors found that even in 1992 over 50% were under-treated and were not
receiving preventive medication. 50

The impact of guidelines on the treatment of a chronic disease such as asthma is dependent
on sustained compliance with the recommendations. Low rates of repeat prescriptions for
preventive medications have been detected in studies of adults and children. A study of
moderate or severe asthmatics 51 (adults and children over 7 years old), showed 63% were
dispensed preventive medications (but only 32% were receiving preventive medications
regularly). Another study" also suggested less than 54% of the patients (adults and
children over 12 years) prescribed anti-inflammatory medications were collecting the
medications regularly. A study of British children indicated 53 very few (less than 15%)
were dispensed preventive medications regularly.

The impact of these NIH guidelines on the emergency department management of
chi ldhood asthma has also been studied54

55

and also revealed that implementation may be

limited. A survey of physicians at academic medical centers with a pediatric residency
program found that at most half of those surveyed believed their emergency management of
asthma was influenced by the NIH guidelines. 54 A survey of physicians based at a sample
of children ' s emergency departments showed that45.5% had heard of the guidelines and
24% had read them. 55

There are many challenges to moving towards providing preventive care for asthmatics and
persuading patients not to only attend either the primary care physician ' s office or
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emergency department for urgent care for acute asthma exacerbations. 56

57

The lack of

regular prescribing of preventive medications for some children may show a need for more
patient education, provider training, and alternative disease management approaches to
introduce the asthma treatment strategies recommended in the NIH guidelines. 58 59 60

Effectiveness of the Nm recommendations for the treatment of childhood
The efficacy of anti-inJlammatory medications at reducing airway hyperresponsiveness was
demonstrated in clinical trials and these results were the basis for development of the NIH
guidelines. 23 Few population based studies have been published on the effectiveness of
anti-inflammatory medications for the treatment of childhood asthma. Many researchers
have focused on severe asthmatics rather than the population treated by primary care
physicians. This population based study reviews the effectiveness of primary care
physicians prescribing preventive anti-inflammatory medications under conditions of actual
use.

Two studies using claims data bases have shown that inhaled corticosteroid therapy caused
a significant reduction in health care service use by asthmatic children. One study reported
asthma medication claims data from 6035 insured (non-Medicaid) asthmatic children, at
Harvard Pilgrim Health Care (HPHC). The HPHC results showed the percentage of
asthma prescriptions dispensed for preventive medications between October 1991 and
September 1994 was respectively as follows: beta-agonists 67%, cromolyn 16% and
inhaled steroids 11 %, theophylline 6%.38 The study by HPHC demonstrated that
preventive medications confer significant protection against exacerbations of asthma leading
to hospitalization, but did not investigate other clinical outcomes.

A retrospective case-control study of asthmatic Medicaid children (less than 12 years old)
used a North Carolina claims database to follow the health care costs of85 cases and 72
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controls for 1 year.6 '

62

The cases began inhaled conicosteroid therapy between March

1994 to 1995. The controls were on asthma therapy other than steroids for a continuous 2year period between March 1993 to March 1996. The study demonstrated that the
introduction of inhaled corticosteroid therapy to Medicaid children was associated with a
significant reduction in the total health care costs (hospitalizations, physician visits,
outpatient visits and the cost of medications).

A cohon study of the relative risk of readmission to hospital by severe asthmatic patients
(age 5-54 years) showed that using inhaled steroids reduced the risk of readmission during
the period 16 days to 6 months after the first admission 63 or of fatal or near fatal asthma n
The studies have not however always demonstrated a protective effect for severe asthmatics
of steroids from readmission of children""' or patients age (5-45 years) 65 to hospitals.

The NTH guidelines recommend education to support self-management, although there are
some conflicting results ex.isl about the efficacy of providing very limited education. Many
of the education studies are however difficult to compare as there are few patients studied,
and the nature of the intervention and duration all vary considerably. Positive effects on
outcomes were found from some programs for children which were designed to promote
know ledge and self-management in asthma. For example, a randomized control trial
studied the impact over 12 months of an initial training program comprising five 1 hour
sessions for the parents and children. This study found an increase in knowledge,
compliance and reduced emergency room visits and days ofhospitalization.66 Reductions
in hospitalizations and emergency room visits have also been obtained from introducing a
pediatric outreach program for an inner city population that were identified as having a
history of using these services.48 Another study of the benefits of introducing a program
for inner city children only showed a significant effect of the program on children whose
episodes of asthma were severe enough to have been hospitalized in the previous year. 67 A
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systematic review and meta-analysis of the published literature on adults concluded that
limited asthma education(information only) for adults reduced emergency department visits
and improved knowledge but did not reduce hospitalizations or physician visits. 68

There is evidence to suggest that co-operation between health care providers, parents and
children is essential to achieve optimal management. 69 Poor knowledge about asthma will
make self-management difficult and lack of parental knowledge has been associated with
readmission to hospital

70 71

or emergency department visits-"

73

Focus groups of urban

minority asthmatic children in New York showed many parents and children had very
modest expectations of symptom control. 74 Asthma was viewed by the families as
"episodic" increasing their emphasis on symptomatic treatment rather than for preventive
visits. Many studies have identified poor compliance with preventive medication amongst
preschool 75and school children 76 as well as with adult asthmatics. 53 7178 Consequently
some organizations are experimenting with approaches to implementing the NlH guidelines
which integrate patient education with careful co-ordination of medical management for
acute and ambulatory care.57 5 8

79
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Table 1 NIH guidelines (1991) criteria for classification of asthma by severity of disease
Characteristics

Mild

Moderate

Severe

Frequency of

Exacerbation of cough and

Exacerbation of cough and

Virtuall y daily wheezing. Exacerbations

exacerbations

wheezing no more often

wheezing on a more frequent

frequent , often severe. Tendency to

than 1-2 times per week

basis th an 1-2 times per week.

have sudden severe exacerbations.

Co uld have hi story of severe

Urgent visits to hospita l eme rgency

exacerbations, but infreq uent.

departments or doctor' s office >3 tim es

Urgent care treatment in hospita l

per year. Hospitali zati on >2 times per

emergency department or

year, perhaps with respiratory

doctor 's office <3 times per year.

insufficiency or, ra rely, respiratory

A. Pretreatment

0

I\.)

failure and hi story of intubation. May
have had co ugh syncope or hypoxi c
seiz ures.

Table I (continued) NIH guidelines ( 1991 ) criteria for classification of a sthma by seve rity of disease
Characteris ti cs - -

Mil_d_ _ _

Moderate

Severe

Freque ncy of

Few clini cal signs or symptoms

Cough and low grade wheezin g

Continuous albeit low grade

sy mptoms

of asthma betw een

between acute exacerbations often

cough and wheezin g almost

exacerbati ons.

presen t.

always present.

Degree of exercise

Good exerc ise tolerance but may

Exercise tolerance dim inished.

Very poor exercise tolera nce

tolerance

not tolerate vigorous exercise ,

with marked limitation of

especia ll y prolo nged ru nnin g.

acti vity.

0

w

Frequency of

1-2 times per month maxi mum

2-3 ti mes per week

Considerable, almost ni ghtl y
sleep inte rrupti on due to asthma.

nocturnal asthma

Chest ti ght in earl y morn in g.
School or work
attendance

Good school or work attendance

School or work attendance may be
affected

Poor school or work atte ndance .

Table 1 (continued) NIH guidelines (1991 ) criteria for classification of a sthma by severity of disease

Characteri stics

Mild

Moderate

Severe

a) Pea k expi ratory

PEFR>80% predi cted .

PEFR 60-80% predicted

PE FR <60 % predicted

n ow rate (PEFR)

Va riability* <20%

Vari ability20-30%

Variabil ity>30%

b) Spiro metry

Minima l or no ev idence of

Si gns of a irway o bstructi on on

Substanti al degree of a irway o bstructi on

a irway obstructi on on

spi ro metry a re ev ident. Flow

on spiro metry. Flow volu me c urve

spiro metry. Norma l expirato ry

volu me c urve s hows red uced

shows marked concav it y. Spi romct ry

fl ow volume curve; lun g

ex piratory n ow at low lun g

may not be no rm ali zed even with hi gh

volum es not in creased.

volu mes. Lung volumes often

dose stero id s. May have s ubstant ia l

Usuall y a > 15% res ponse to

increased. Usua ll y a > 15%

increase in lun g volumes and ma rked

acute ae rosol bronchod il ato r

respo nse to acute aerosol

unevenness of ventil ati on. Incomp lete

administration, even though

bronchod il ator ad mini stra tion.

reversibility to ac ute aerosol

Pulmonary function

0

"""

bronchodil ator adm ini stration

baseline near normal.
c)Methacholine
sensiti vity

Methacholine PC20>20mg/ml

Methacholine PC202-

Meth ac ho lin e PC20 <2mg/ml

20mg/ml

*Vari a bility: the difference between a mornin g and evenin g measure or a iiiong n1ornin g measurement s eac h clay fo r a week.

Table 1 (continued) NIH guidelines (1991 ) criteria for classification of asthma by severity of disease

Characteristics

Mild

Moderate

Severe

Response to bronchodilators in

Periodic use of bronchodilators

Requires continuous around the

B. After optimal
thernpyis
established
Response to and
duration of therapy

12-24 hours, regu lar drug

required during exacerbations fro a

clock drug therapy including

therapy is not usuall y required

week or more. Systemic steroids

daily cort icosteroids, either

except for short periods of time.

also usually required for

aerosol or system ic, often in high

exacerbations. Con tinuo us a round

doses.

0

U'I

the clock dru g therapy required.
Regular use of anti-innarnmatory
agents may be required for
prolonged periods of time.
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APPENDIX B

DETAILS OF THE METHODS

Data source and study population
The data analyzed were from a sample of children (aged 2 to 19 years) treated for asthma
during 1994 by the Medicaid program in Pennsylvania, USA. The data were collected
during a medical care evaluation for the Department of Public Welfare of the
Commonwealth of Pennsylvania.

Medicaid is a program financing medical care for qualifying low-income patients. The
eligibility fortreatment of children under a Medicaid program is influenced by the parents '
income and employment status. A substantial loss of patients due to changes in enrollment
status have been reported in a 5 year period.' This study was restricted to children eligible
for Medicaid enrollment as a minimum for 1994. This time frame is appropriate for
studying the outcomes of treatment of childhood asthma because the study was evaluating
medication effects which have a rapid onset of action and a reduction in acute asthma
exacerbations could be expected to be observed in this time frame.'

The data sources for the analyses were the primary care medical records and hospital and
emergency department encounter files. Automated medication claims records were
provided for comparison with the medical records of 106 patients.

The data elements in Medicaid files that are required for claims payment are considered to
have generally good accuracy.' However data that are not directly related to claims
payment, may be of poorer quality and should be verified. This study included a check of
the reliability of the primary care medical records as a source of information on asthma
medications by comparing the agreement with medication claims.
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Sample size and sampling strategy
Each plan was requested to identify all Medicaid members who were diagnosed and treated
for asthma during 1994 (International Classification of Diseases, Ninth Revision. Clinical
modification code ICD-9=493) and select a random sample of 50 children (aged 2 to 19
years in 1994) for study.

The asthma diagnoses were confirmed by nurse reviewers checking the primary care
medical records and therefore the study did not rely solely on the !CD 9 coding for the
asthma diagnosis. Patients without a diagnosis of asthma in the medical records were not
included in the study.

The NIH guidelines include an algorithm for differential diagnosis of asthma and
recommend a detailed medical history checking for key indicators for a possible diagnosis
of asthma. physical assessment and then pulmonary function testing(spirometry) to
establish the diagnosis.' Mild to moderate cases of asthma may be difficult to diagnose,
especially among young children. The guidelines summarize differential diagnosis of
asthma and indicate that wheezing by children due to asthma is often confused with
wheezing due to recurrent respiratory infections. Reliance on the ICD-9 code alone without
verification with the medical records would have been inappropriate for identification of a
sample of asthmatic children.

The age of the children I stJanuary 1994 was calculated from the date of birth. The age
range of children included in the cohort was verified to be 2 to 19 years old. Children
younger than 2 years old or over 19 years were excluded from the study.

The plans provided 388 medical records and 347 were eligible after verifying the patient ' s
age on Ist January 1994 was between 2 to 19 years old (41 were less than 2 years old).
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311 were eligible after confinning there was an asthma visit date with documentation of a
prescription for an asthma medication during 1994 (36 out of 347 did not have
documentation of a visit during 1994).

Data collection
A data collection instrument was created and abstracting instructions were provided to the
nurse reviewers. The data collection was conducted on-site, with a separate data collection
instrument for each patient. No data was collected directly from the physicians or patients.
The data on asthma treatment provided by plan physicians between !st January 1993 and
31st March 1995 were abstracted from the medical records.

The nurse reviewers were asked to abstract data on the five most recent asthma related
hospital admissions and emergency department visits from January 1993 through March
1995. For each hospitalization or emergency department visit the nurse reviewer
documented the admission dates, discharge dates and reason for visit or admission. The
reasons listed on the data collection instrument included patients lack of compliance, wrong
treatment plan , unusual exposure to tri gger, lack of guidance for medication late
notification. other and not documented.

For each primary care physician visit the nurse reviewer was asked to abstract from the
medical record all the asthma related medications prescribed on each visit date between
January 1993 through March 1995. Medication data abstracted from the medical records
included details of the asthma medications prescribed (product name, route, directions,
days supply), date prescribed and prescriber (primary care physician or other).

The clinical data abstracted included date of birth, gender, date of initial asthma diagnosis,
date of latest theophylline level , date of latest influenza vaccination . The data also included
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the date of each physician visit (up to 10 visits), the types of patient education provided at
each visit (abi lity to use peak flow meter, ability to use inhaler. how to use inhaled
medications, side effects of medication, avoidance of triggers, action plan for
exacerbations, use of diaries. and goals of treatment). For each visit there was a record of
height, weight, blood pressure, a physical examination , medical history (symptoms and
functional status), objective measures oflung function (peak expiratory flow rates, home
use of a peak flow meter, spirometry results) and referrals to specialists (dates, type of
specialist, reason). These were all recorded for each visit as·' yes·. ""no" or "not
documented in the record". In addition the instrument allowed '·not applicable " to be
recorded for ability to use peak flow meter, ability to use inhaler. how to use inhaled
medications, or side effects of medications.

The nurse used the information in the medical records and the NIH guidelines( 1991 )3 to
classify the asthma severity at each primary care visit as mild, moderate or severe asthma.
In the past the diagnosis criteria have varied for classifying asthma severity but the NIH
guidelines include a working definition of mild, moderate and severe asthma severity.
Access to the medical records allowed the NIH guidelines to be used to classify the children
as mild , moderate or severe asthmatics at each physician visit when an asthma medication
was prescribed. The analyses were then able to address confounding by asthma severity
for example by stratified analyses and including a time dependent covariate for asthma
severity in the Cox regression model.

Medication claims from 4 managed care plans were also provided for a sample of I06 of
the children (aged 2 to 19 years) treated for asthma during 1994. The medication claims
data included all the asthma medications dispensed (product name) and date dispensed.
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The data recorded on the instrument were entered into a database and transferred with the
automated medication claims records to the Department of Applied Pharrnaceutical Sciences
at the University of Rhode Island.

Data coding and screening
The analyses were all perforrned using SAS 6.12. A SAS program was written to ensure
that any duplicates of patient records were deleted. Missing values were changed to be
represented by a single code for all the variables. Univariate descriptive statistics were
examined using programs such as ' Proc Univariate'. A series of checks were made to
ensure codes had been programmed appropriately. For age the range of the values, mean
and standard deviations were checked to confirrn these were plausible.

Asthma severity was coded as mild ( I), moderate (2) or severe (3) at each physician visit.
The maximum asthma severity recorded during the study period was used to classify the
children into mild, moderate and severe asthmatics.

Asthma medications were coded as dichotomous variables :beta-agonists (oral or inhaled),
preventive anti-inflammatory medications (i nhaled corticosteroids, inhaled cromolyn or
nedocromil), oral theophylline or oral corticosteroids. The asthma medications were
recorded by generic or Trade Names, so the coding of the asthma medication variables
were carefully checked to ensure none of the medications had been missed and were
recoded appropriately. Data on the route of administration was missing fortoo many
patients to code oral or inhaled beta-agonists separately.

The seasons were coded as a dichotomous variable for each physician visit. The fall to
winter season was coded as 1st October to 31st March.
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The dates for hospital admission and emergency department visits were used to determine
whether the patients experienced these outcomes within the defined time period. Each
variable was coded I for each patient experiencing an event or zero for those not having the
event within the defined time period.

The data for each patient was transposed to create a data set containing one record per
patient. Each record contained the demographic information, plus asthma severity and
medications for each primary care physician visit (maximum 10 visits). If the patient
attended less than ten visits the data was coded as missing for the remaining visits. A SAS
program was written to code the children as receiving undertreatment at each visit where the
asthma severity was moderate or severe and no preventive medications were prescribed.
For example; each record contained a unique patient identifier code, age, sex , hospital
admission (0, I), emergency department visit (0, I), plus for each visit date asthma severity
(coded 1.2,3), preventive medications {0, I), oral steroids (0, l ), undertreatment (0, l ) or
season (0, l) etc.

For all the analyses the data collected was censored for 31st December 1994. All the data
collected before l st January 1993 or after 3 l st December 1994 were excluded from the
analyses. For example, some hospital admissions were documented for patients for before
Ist January 1993 and these were excluded form the analyses.

For the analyses using data for the period l stJanuary 1994 to 31st December 1994 the data
before !st January were excluded from the data set. For the Cox regression analyses the
beginning of person-time for an individual was defined as the date of the first physician
visit when an asthma medication was prescribed between !st January 1993 and 31st
December 1994. The end of person-time was defined as the first date for the outcome
under evaluation after the first physician visit (either a hospital admission or an emergency
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department visit for asthma or a course of oral steroids) orthe end of the study period (31 st
December 1994).

Prescribing anti-inflammatory medications in accordance with the NIH guidelines was
determined by the following dichotomous variables: preventive medication (prescribed at
least once) , preventive medication prescribed at 50% or more of the visits when other
asthma medications were prescribed, undertreatment (preventive medication was not
prescribed at least once when the children visited the primary care physician with moderate
or severe asthma) or undertreatment at 50% or more of the visits when other asthma
medications were prescribed.

Forche reliability assessment, the medication claims data selected included the medication
data (using date dispensed) for between January to December 1994. The medical record
and medication claims data sets were merged using a unique patient identifier code and any
unmatched records were not included in the analyses. The medication claims data before
the first physician visit were not included in the analyses. Dichotomous codes were created
for oral steroids and preventive medications dispensed using the medication claims records.

In order to have confidence in the reliability of the study results the drug exposure
classification using medication claims data was compared with the primary care physician
medical records, which were the main source of data for our study. Nondifferential
misclassification of dichotomous variables may bias the risk estimates towards the null
value. 4 but if there is differential misclassification then the effects on relative risk estimates
are unpredictable. 5

The kappa statistic is commonly published in papers to demonstrate the reliability of a
method for dichotomous variables.• The agreement between the medical records and
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claims forthe medication dispensed was evaluated by calculating the percent agreement and
kappa statistic for two dichotomous medication exposure variables (oral steroid course and
preventive medication). In addition differential misclassification of exposure status was
evaluated by calculating the kappa statistics for each group of children divided up by
outcome.

Multivariate analyses
The outcomes studied were too infrequent to be analyzed as continuous variables, very few
patients had more than one event during the study. The outcomes were therefore coded as
dichotomous events. Cox regression was therefore the multivariate methods selected for
the analyses of the clinical outcomes. For the logistic regression analyses the data analyzed
was collected during 1994. The Cox regression analyses were able to adjust for the
person-time contributed to the data set and allowed all the data collected between January
1993 and December 1994 to be included in the analyses. Both methods allowed the
creation of models from a combination of independent variables which are continuous,
categorical, or discrete. Unlike many of the multivariate methods assumptions of
multivariate normality, linearity and homoscedasticity are not required for the predictors
included in the models.

The SAS procedure PROC PHREG was used for the Cox regression analyses,7 and PROC
LOGISTIC was used for the logistic regression analyses. The analyses used PROC
PHREG so that both fixed and time dependent covariates could be included in the models.
The coding of data and programming was complex in order to organize the data
appropriately for PROC PHREG. The programs were developed from studying examples
provided in SAS users' guides. 8 9

10
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The analyses included fixed covariates for preventive medications and preventive
medications prescribed at the last visit before the event, so the proportional hazard
assumption was checked. The assumption was examined graphically using PROC
LIFEfEST by checking the plots of cumulative hazard (i.e. log negative log survival
probability) against log survival time can be considered parallel for selected dichotomized
covariates.

The linearity of the association of continuous variables with each dependent variable
studied were examined and the variables coded appropriately before the analyses were
progressed, for example. age was dichotomized for some of the multivariate analyses.

Many of the drugs for asthma can appear to increase risk of adverse outcomes because the
patients for whom asthma medications are prescribed may have an increased risk of
frequent and severe asthma exacerbations.'' Consequently to address confounding by
asthma severity, the multivariate analyses selected the children attending with either
moderate or severe asthma before the outcome, included a covariate for severity or for Cox
regression included severity as a time dependent covariate. The logistic regression analyses
were able to stratify the patients by the maximum asthma severity recorded during the
study. This is in line with NIH guidelines which classify patients as mild. moderate or
severe based on the history before the asthma is treated.

The introduction of time dependent covariates allows the status of each individual to vary
during the study and the Cox regression model no longer assumed the effect of the
covariate was the same at all the time points, even when recorded at irregular intervals. The
models were able to include time dependent covariates for asthma severity and preventive
medications. The Cox regression analyses used both fixed covariates for age or gender
and time dependent covariates.
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APPENDIX C

OVERVIEW OF MAJOR FINDINGS

There were three major findings from this study of the impact of the NIH guidelines on the
treatment of childhood asthma by primary care providers:

I) primary care providers imple"*'1ted the NIH recommendations by prescribing inhaled

anti-inflammatory medications at least once for 61.1 % of the chi ldren with moderate or
severe asthma during 1994

2) the NIH recommendations to provide patient education were not fully implemented by
the primary care providers because only 41.8% of the children received any patient
education during 1994

3) prescribing preventive medications to children with moderate or severe asthma reduced
the risk of being prescribed courses of oral steroids (HR 0.42. 95% Cl 0.19-0.95) , after
adjusting for age and asthma severity.

The results from this study demonstrate the potential impact of the NIH recommendations
on the clinical outcomes of asthmatic children. There may be an opportunity to further
improve the outcomes for asthmatic children by supporting physicians and pharmacists to
more fully implement the NlH recommendations for all the children with moderate or
severe asthma.

NIH guidelines recommend treatment of moderate or severe childhood asthma with
preventive anti-inflammatory medication (inhaled corticosteroids, cromolyn or nedocromil) .
The guidelines emphasize the importance of patient education about avoidance of triggers
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and the management of asthma (written action plan for exacerbations. goals of treatment
and how to use an inhaler).

Children with moderate or severe asthma during 1994 were prescribed a beta-agonist
(96%) and 61.1 % were prescribed preventive medications at least once. The NIH
recommendations were not followed regularly because only 27.0% of the moderate or
severe asthmatics were prescribed preventive medication more tban once during the year.
In addition , providing patient education was only recorded for 41.8% of the children.

The results suggested that the prescribing of preventive medications is related to sentinel
clinical events and the NIH recommendations are not always routinely implemented for
chi ldren with moderate or severe asthma. Logistic regression analyses indicated
prescribing preventive medication was associated with moderate or severe compared to
mild asthma (aOR 5.34, 95% CI 3.22-8.83) and age 5 to 19 years compared to 2 to 4 years
(aOR 2. l l , 95% CI 1. 19-3.72). Prescribing preventive medication was also associated
with a prior emergency department visit (aOR 2.27, 95% CI 1.244.16), after adjusting for
age.

Children younger than 5 years of age are recommended to be given courses of oral steroids
for chronic severe asthma because they may be unable to use inhalers effectively. The NIH
guidelines for the use of preventive medications were implemented on at least one occasion
for 66.7% of the children aged 5 to I9years old with moderate or severe asthma during
1994. The prescribing was not therefore consistent with fully implementing the NIH
guidelines for all the children attending with moderate or severe asthma; even after taking
into account the difficulty of treating children under 5 years old with inhaled medications.
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The NIH guidelines recommend anti-inflammatory medications but indicate that
theophylline can be prescribed for childhood asthma. In this study the prescribing rates for
theophylline were very low (4.8%). and cannot therefore account for the apparent
undertreatment of moderate or severe asthmatics with inhaled anti-inflammatory products.

The low rates of repeat prescriptions for antinflammatory products amongst the children
with moderate or severe asthma in our study cannot be fully explained by poor patient
compliance with follow-up primary care visits. In our study, lack of continuity of care
cannot completely explain the results because 38.9% of the children with moderate or
severe asthma attended the primary care physician more than once and were not prescribed
preventive medications. Low rates of repeat prescriptions for preventive medications were
also obtained in other studies, although these included both adults and children. 1 '

3

Inadequate attendance for primary care physician follow up visits were shown by a study in
asthmatic children in the Medicaid program in Massachusetts.<

The reasons for not prescribing preventive medications to all the patients with moderate or
severe asthma are not known in the current study. Under-treatment of asthmatic children
has however also been recorded in three other studies which reported that at least 50% of
the children were not prescribed preventive medication before either an admission to
hospital or attending the emergency department. 5 6

7

The NIH guidelines on the importance of on-going patient education and self-management
of asthma do not appear to have been widely implemented by the primary care physicians
during this study period. Patient education was documented for less than 50% of the
children during 1994, regardless of the type of education. Action plans for severe
exacerbations were the most frequent form of patient education provided and were given to
the majority of severe asthmatics. Fewer than 25% of the children with moderate or severe
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asthma were documented in the medical records as being provided information on the
treatment goals or having the ability to use an inhaler correctly confirmed during 1994. No
education on avoidance of environmental triggers was given to at least two thirds of the
children with mild or moderate asthma and over a third of the children with severe asthma.

In this study increasing asthma severity was associated with review of treatment goals. an
action plan and the avoidance of triggers. There was no indication that children received
additional patient education after either an emergency department visit or hospitalization .
Prescribing preventive medication was associated with the provision of patient education
(after adjusting for age and asthma severity), consequently children without preventive
medication were also less likely to receive counseling.

One limitation of our study was the use of medical records to evaluate patient education as
the quality of the education routinely provided could not be assessed. The extent of the
education provided may also have been underestimated ; for example the ability to use an
inhaler may be checked by pharmacists and not recorded in the medical records. In
addition, education may be provided to the patient but not documented in the medical
records by the health care provider.

These results could be explained by differences between physicians or managed care plans
in the extent to which NIH guidelines are implemented. The study design did not include a
sample size large enough to allow comparisons between the different managed care plans or
profile the prescribing practices of individual prescribers. For example, asthma specialists
have been shown to be more likely to prescribe preventive medications than primary care
physicians" 9 and access to or co-ordination of care by specialists 10
implementation of the NIH guidelines by some plans.
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11

may have facilitated

Prescribing preventive medication to children with moderate or severe asthma reduced the
risk of being prescribed oral steroid courses. Cox regression analyses were conducted
with time dependent covariates for being prescribed preventive medications and adjusting
for asthma severity (mild, moderate or severe) , with a fixed covariate for age. Children
diagnosed with moderate or severe asthma at least once who were prescribed preventive
medication were less likely to require a course of oral steroids (Hazard Ratio 0.42 95% CI
0.19-0.95) , after adjusting for age and asthma severity. No significant association was
found using Cox regression between prescribing preventive medications and hospital
admissions or an emergency department visits.

Emergency department visits were shown in our Cox regression analyses to be consistently
associated with prior severe asthma exacerbations or a course of oral steroids. The Cox
regression models included asthma severity and preventive medications as time dependent
covariates but could not also include oral steroids because of multicollinearity with asthma
severity. A course of oral steroids is recommended by the NIH guidelines for the acute
treatment of severe asthma exacerbations and therefore may have reduced the risk of
adverse outcomes from undertreatment with inhaled anti-inflammatory medication. For
example, one study showed starting or increasing steroid medications at the onset of a cold
or flu reduced the odds of asthmatic children making an emergency department visit. 5

A disproportionate number of Medicaid children have been shown to rely on the emergency
department instead of primary care providers for their asthma care 12 and some parents
prefer to use the emergency department. 13

'"'

These patient and various health care system

characteristics all pose challenges to Medicaid patients moving away from episodic
attendance for crisis orientated, fragmented care for asthma exacerbations. 15
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16 17

In our study emergency department visits were more common amongst 2 to 4 year olds.
The NIH guidelines recognize this age group is less likely to be able to successfully coordinate inhaling preventive medication . and may have to rel y instead on courses of oral
steroids for acute exacerbations. The 0 to 4 year age group has been found to exhibit
higher hospitali zation rates for asthma than other age groups 18

19

and there is evidence of

children aged 2 to 4 years old making more emergency department visits. 20 21

One predisposing factor for emergency department visits or hospital admissions seems to
be the season of the year as more events were recorded during fall or winter. Similar
results have also been recorded in other studies and viral infections have been suggested as
a possible explanation for these seasonal trends. 22 23 In our study, it was not known
whether a viral infection was considered the trigger for the asthma-related emergency
department visit or hospital admission. Seasonal influences may explain why
undertreatment at the last primary care physician visit before an emergency department visit
or a course of oral steroids was associated in the Cox regression analyses with a
significantly increased risk of both these adverse outcomes. The Cox regression analyses
also included a time dependent covariate for season but the small sample size and low event
rates may have prevented the study detecting an association between preventive medications
and hospitalization or emergency department visits.

Only a few population based studies have been published on the effectiveness of antiinflammatory medications for the treatment of childhood asthma, many of which have
focused on severe asthmatics. However, a case control study of Medicaid children
showed prescribing corticosteroid therapy was associated with a significant reduction in the
total health care costs (hospitalizations, physician visits, outpatient visits and the cost of
medications). 24 Similarly, two studies of asthmatic children demonstrated preventive
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medications confer significant protection against exacerbations of asthma leading to
hospitalization. 25 26 A cohort study of the relative risk of readmission to hospital by
asthmatic patients (age 5-54years) showed that using inhaled steroids reduced the risk of
readmission during the period 16 days to 6 months after the first admission " or of fatal or
near fatal asthma. 28 Other studies have not however always demonstrated a protective
effect for severe asthmatics of steroids from readmission of children'" or patients age (5-45
years) 30 to hospitals.

The information about prescribing medications was collected from the medical records
rather than a separate medication claims database, consequently not all the prescriptions
may have been actually dispensed or administered regularly as directed. Patient compliance
is important for preventive medications to be beneficial and for children it may be especially
complex as parents, school nurses and other carers may have to administer the medication.
Many studies have identified poor compliance with preventive medication amongst
preschoo1 31 and school children. 32 Patient compliance was not measured in this study,
therefore these data may underestimate the value of prescribing preventive medication to
these children.

The information collected from this Medicaid asthmatic population may not be generalizable
to other children. 33 The Medicaid eligibility criteria for this study means all the children
were from poor families. It was not possible to compare the results from this Medicaid
group with other patients attending these plans. In the present study medications were free
for the patients; thus there was no cost incentive for patients to avoid having prescriptions
dispensed for preventive medications.

The managed care plans guarantee access for these Medicaid patients but there are many
differences between poor minority families and health care providers that may influence

134

prescribing practices for example language. cultural barriers. or literacy levels.34 Indoor
allergens, such as cockroaches, dust mites. pets or cigarette smoke are now recognized as
important triggers for asthma, which may be particularly difficult for Medicaid eligible
children to avoid. 35 36

The low socioeconomic status of these children means they might be unable to avoid some
environmental triggers, have a higher frequency of severe asthma,37
lack of continuity of care more than insured children

38

and experience a

15 16 17

or under-use preventive services

for asthma. 39 4 The effectiveness of prescribing in accordance with the NIH guidelines was
still however, clearly demonstrated as preventive medication significantly reduced. and
undertreatment of moderate or severe asthma significantly increased the risk of prescribing
a course of oral steroids. Reducing the asthma exacerbations requiring oral steroids would
be expected to improve the quality of life for the children.

This population-based study supports the effectiveness of prescribing inhaled preventive
anti-inflammatory medication under conditions of actual use by a Medicaid population.
This study shows that primary care physicians can improve the control of asthma by
implementing the NIH guidelines and regularly prescribing anti-inflammatory medication
for moderate or severe asthma. Our results also showed there was limited implementation
of the NIH recommendations for prescribing preventive medication and providing patient
education, which may have reduced the impact of the guidelines on improving the
management of childhood asthma. This study supports the need for interventions to
increase implementation of the NIH guidelines by primary care physicians and improve the
treatment of childhood asthma.
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